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1.1 Introduction 
 
In children born with a cleft lip and palate infant orthopedics (IO) is 
performed during infancy mainly in order to facilitate feeding, to reduce 
the cleft width and to normalize and maintain the shape of the upper 
dental arch, pre and post surgery. This treatment modality has been part 
of the unilateral cleft lip and palate (UCLP) treatment protocol in almost 
half of the European cleft lip and palate centers.1,2 However, since the 
introduction by Mc Neil2-5 half a century ago, proponents and opponents 
have been discussing its’ effectiveness. The main reason for this long 
lasting controversy was the lack of scientific evidence to support the 
indication and use of IO. This ongoing discussion led to the great debate 
on the effectiveness of IO at the 47th meeting of the American cleft 
palate association in St Louis.6 The debate as well as the impossibility to 
perform a systematic review or a meta-analysis into the effectiveness of 
IO, due to lack of evidence based information, marked the initiation of a 
comprehensive randomized controlled trial into the effects of infant 
orthopedics in the Netherlands, called “Dutchcleft”. 
 
 
1.2 Epidemiology 
 
Orofacial clefts are the most frequent craniofacial anomalies (CFA), and 
are sometimes associated with other congenital anomalies and 
syndromes. According to the WHO7 one in every 600 newborn babies 
worldwide is born with a cleft lip and/or palate. This means that, 
assuming 15,000 babies are born per hour worldwide, a baby is born with 
a cleft somewhere in the world every 2 minutes. However the birth 
prevalence varies a great deal geographically from 2.7:1000 in Native 
Americans to 2.1:1000 in Japan and to 0.4:1000 in Nigeria and 0.4:1000 
in African Americans. The geographical variation seems to be less 
important than the ethnic differences. Cleft palate only seems to be much 
less dependent on racial and ethnic differences than CLP. Frequencies of 
the nonsyndromic cleft lip and/or palate range from 70 to 80% of the total 
cleft population.8 In males cleft lip and palate appears more frequently 
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than in females (ratio m:f = 2:1), the opposite is seen in cleft palate only 
(ratio m:f = 2:3), but little is known about time trends, variation by socio-
economic status or seasonality.7  
In the Netherlands the prevalence varies annually. For the period 
between 1996 and 2003 the incidence ranged from 292 to 340 live born 
babies per year, the prevalence ranged from 1.54 to 1.87 per 1000 live 
born babies.9  
 
 
1.3 Non-syndromic cleft lip and palate 
 
The non-syndromic cleft lip and palate is a complex, multifactorial 
disorder. Current genetic research is focusing on the role of genes, 
genetic susceptibility as well as gene/environment interactions.7,10 
Identification of genes that predispose to orofacial clefts would make 
possible the identification of those at risk, enhance understanding of 
pathogenesis, and facilitate the study of gene-environment interaction, 
which could be translated into prevention strategies. Some evidence is 
available about the involved genes and environmental influences 
(nutrition, health-factors and lifestyle) associated with cleft lip and or 
palate. Identified candidate genes are: transcription regulators, growth 
factors, signaling molecules and RYK-gene.11,12 These factors interact in 
a series of intra- and intercellular events that culminate in a 
developmentally significant pattern of gene expression. When the 
structure or expression of these genes is modified a cleft of some type 
may occur. Identified factors contributing to the risk of CLP are: 
maternal tobacco smoking (20-30% increase in the risk), prenatal alcohol 
exposure, as well as potential gene-environment interaction with alcohol 
and certain genes, maternal diabetes and obesity have also been linked to 
an increased risk. Nutritional factors include vitamin A, riboflavin, folic 
acid, panthothenic acid, vitamin B12, B6 and zinc.10,13 
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1.4 Clinical features and developmental issues of nonsyndromic cleft  
 lip and palate 
 
In clefts of the maxillofacial area, the upper lip, alveolus, and the hard 
and soft palate are the most frequently affected parts. Clefts of other parts 
of the face are very rare. Classification can be based on etiology, 
pathogenesis, be anatomic based or based on embryology. Clefts can 
occur unilaterally or bilaterally (left and right sided) and be submucosal 
(cleft muscle or bone), partial (including Simonarts’ bands) or complete. 
The sidedness is distributed according to the ratio left:right:bilateral = 
6:3:1.  
In unilateral cleft lip and palate intrinsic developmental deficiencies, 
functional distortions and superimposed iatrogenic factors attribute to the 
appearance and function.14-20 The intrinsic abnormalities are mainly 
within the maxillary complex, they are mild in most cases and the growth 
potential is near to normal.15 The altered function due to the cleft in the 
lip and/or palate causes the distortion of both normal and abnormal parts 
and is responsible for the apparent severity of the condition. However 
facial asymmetries are in most cases reversible by surgical repair. 
Although the cleft subgroups vary in severity and subsequently in growth 
potential, iatrogenic factors and surgical limitations are probably the 
major source of midfacial deficiency and functional problems reported in 
patients with CLP.16-22  
In combination with different racial and ethnic backgrounds, 
different treatment protocols and varying experience of the involved 
professionals, different treatment outcomes can be expected between the 
subgroups (cleft lip and/or palate, bilateral/unilateral, complete/ 
incomplete) and different cleft palate centers. For these reasons 
evaluation of the effectiveness of any kind of treatment should be 
performed within the appropriate (cleft type and ethnic) subgroups; 
treatment protocols should be clear and well described and adhered to by 
the involved professionals. Professionals should be experienced with 
preferably high volumes of cleft patients. 
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1.5 Implications of cleft lip and palate 
 
In the report of the WHO meetings on international collaborative research 
on craniofacial anomalies,7 the following was summarized concerning 
CFA: “Cleft lip and palate are serious birth defects. The impact of CFA 
on hearing, speech, appearance, and cognition has a prolonged and 
adverse effect on health and social integration. The consequences and 
costs in terms of morbidity, health care, emotional disturbance and social 
and employment exclusion - in short quality of life (QoL) - are 
considerable for affected individuals, their families and society”.  
 
1.5.1 Psychosocial impact 
The quality of life for a patient with CLP is already influenced at birth by 
the impact of the condition on the infant, mother and family. Looking at 
the problems from an emotional/psychological point of view the parents 
have to adjust to the loss of the anticipated perfect child.23 From a 
philosophical perspective according to Isarin24 the birth of a child with a 
CLP raises controversial emotions in the parents especially in the mother. 
The contradictory feelings, clashing interests of the mother and others 
and the conflicting ideas about what is best for the child illustrate the 
complexity of the relationship. 
Parents of disabled children learn out of necessity, they learn a lot, 
quickly and eclectically. This knowledge minimizes the fear of the 
unknown, is a buffer against pain and makes it possible for parents to 
believe in their own judgments. Knowledge also enables one to learn to 
live without hope and to determine when hope for cure or improvement 
should subside to acceptance of the incurability or imperfection. 
Potential risks for individuals having CFA include reduced peer 
acceptance, cognitive function and social skill development. Although 
psychopathology is not often an associated feature for individuals with 
CFA there are studies, which report the prevalence of anxiety, 
depression, inhibition, low self-esteem, reduced achievement in school, 
and parental stress.25,26 A recent systematic review27 of psychosocial 
effects of cleft lip and palate, confirmed these findings.25-26 The majority 
of children and adults did not experience major psychosocial problems 
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although behavioral problems, satisfaction with appearance, depression 
and anxiety have been reported. The last trend within this theme is, that 
from an ethical viewpoint, authors suggest that it is about time to shift the 
emphasis in the approach to the patient, and equally important the 
approach for future research, from negative to positive, from deficit to 
strength in order to locate and identify sources of resilience and strategies 
of coping.26,28-30 
 
1.5.2 Somatic consequences 
From the somatic point of view the complete UCLP is associated with 
several anatomical defects and functional problems. The lip, nose and 
alveolus have a cleft at the left or right side. The smaller segment is 
usually located dorsally and the anterior part slightly curved upwards in 
respect to the larger segment. In wide clefts this results in a flattened 
stretched alar base on the cleft side. The cleft continues into the palatal 
part of the maxilla and the palatal bone where it is cleft at the level of the 
nasal septum separating the smaller and larger segment all the way 
through the palate. Sometimes the palate is cleft bilaterally to a certain 
extent revealing most of the nasal septum intraorally. In wide clefts the 
tongue in rest is sometimes twisted into the nose. Not only the skin, the 
gingiva, the palatal and nasal mucosa and the bone are not fused but also 
the orbicularis oris muscle and the muscles of the soft palate. The origin 
and attachment as well as the orientation of the muscle fibers are altered. 
Feeding is the first and most important function that may be impaired. 
Due to the cleft palate it is impossible for the infant to generate negative 
pressure31 in order to extract milk from the breast or a regular feeding 
bottle, and thus special feeding bottles are required. 
Other functional problems due to the cleft are numerous. Frequently the 
infant will be at risk to aspirate milk and swallow air. The lip function is 
altered. The often curved nasal septum can cause impaired nose 
breathing. Impaired ventilation of the Eustachian tubes can increase the 
risk of ear infections causing hearing problems and subsequent 
impairment of language and speech development. Intelligibility can be 
inadequate due to impaired language development in case of partial 
deafness, insufficient length of the repaired soft palate and incorrect 
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tongue (tip) position. Also constant colds and hypernasality will have a 
negative effect on intelligibility. 
Facial appearance at rest and in function is variably impaired in both 
unoperated as well as in operated UCLP. In the latter group impairment is 
mostly due to visible scars, scar tissue limiting function, impaired muscle 
functions and asymmetries. All in all social integration may be affected 
from late childhood and on.  
Dental problems are characterized by agenesis, malformation, 
ectopic eruption or impactions of teeth in the cleft area, and dental caries. 
The increased risk and prevalence of dental caries is due to compromised 
oral hygiene (scar tissue, crowding, ectopic eruption of teeth), enamel 
hypoplasia, infant orthopedics, orthodontic appliances and socio-
economic status.32-34 A narrow palate, collapse of the alveolar segments, 
anterior and posterior cross bites, impaired forward growth of the maxilla 
and posterior rotation of the mandible are the most frequent orthognathic 
problems.16-21,35,36  
 
 
1.6 Care and team concept 
 
Patient care is a comprehensive construct. It is connected to ethics, 
culture, politics and metaphysics. Ideally the attitude to care combines 
factors like insight (wisdom), judgment, concern, attention, decisiveness 
and determination to action. Other important phenomena in relation to 
care are power, judgment, honor, pleasure/satisfaction, respect, 
acknowledgement, need, vulnerability and corporeal interaction. The 
contents of care can only be determined in relation to the concerned 
object. The right attitude to care as well as the way it is executed, 
however, has not yet been established.37 One of the current attitudes to 
care of children with UCLP is that they should be monitored and treated 
within the setting of a limited number of craniofacial or cleft lip and 
palate teams. The most important reasons are the apparent 
multidisciplinary approach to this condition as well as the need for 
expertise and routine of the professionals. The involved professionals are 
challenged by the anatomical, functional, and emotional problems. They 
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also have to be able to set realistic treatment goals for each individual 
patient. 
Infants born with UCLP are submitted to many treatments in order to 
repair the defects and treat the functional problems i.e.: infant 
orthopedics, reconstructive surgery, ENT therapy, speech therapy, 
pediatric guidance, psychological support, orthodontics and dental 
reconstruction. The surgical treatment protocol for UCLP includes: 
reconstructive surgery of the lip, nose and (soft) palate during infancy, 
sometimes velo-pharyngeal surgery in early childhood, and bone grafting 
in the cleft area usually around the age of 8-9 years. In some cases 
secondary plastic surgery and/or orthognathic surgery is necessary at 
later stages. 
 
 
1.7 Infant orthopedics 
 
In the early fifties of the last century Mc Neil, a pediatric dentist, 
introduced a treatment modality that would narrow the cleft in infants 
with UCLP in order to facilitate surgery, prevent undesirable effects of 
lipclosure on the dentition such as collapse of the dental arch and the 
subsequent development of cross bites, and favor speech development.3-5 
From clinical experience it appeared to Mc Neil that the optimal time for 
initiating orthopedic treatment with plates was dictated by the period of 
greatest acceleration of growth of the maxillofacial complex. This led to 
the idea to introduce mechanical measures from birth to 7 months of age. 
His approach was mainly based on clinical experience and was never 
evaluated scientifically. Nevertheless the concept of infant orthopedics 
was quickly adopted in many centers around the world.2,38-51  
The first appliances were semi-active or active plates. Semi-active 
plates were constructed on plaster models after alignment of the alveolar 
segments by sectioning the plaster models; Active plates were 
constructed with palatal screws or springs and sometimes pinned to the 
underlying bone. Both types of IO were often used in combination with 
extra-oral strapping in order to push and rotate the alveolar segments 
together. The effects of this new treatment modality, which was at that 
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time used in combination with early bonegrafting, resulted in severely 
impaired forward growth of the maxilla. The use of IO was therefore 
much criticized from the beginning.49,52,53 
Some years later another type of IO was introduced, the passive 
plates.54,55  The objectives for the passive plates are the same as for the 
active ones with the difference that the users of the passive type claim 
that the intrinsic growth becomes manifest without manipulating the 
maxillary segments. In 1993 Grayson and Cutting introduced the latest 
form of IO: naso-alveolar molding (NAM). Their objective was to 
precisely shape the nasal cartilages in addition to molding the alveolar 
segments, by using a molding plate with nasal stents and extraoral 
taping.51,56 Currently the plates related to the Zürich approach as well as 
plates related to the former types are all still part of the treatment 
protocol in almost half of the European centers.1  
The description of IO as used in the three participating centers of 
this study is based on the coordinated management of CLP as carried out 
in Zürich since 1969/1970.54,55,57-60 The main objectives for IO in the 
Zürich approach are: monitoring function (improving feeding and tongue 
posture), and guidance of the growth and position of maxillary segments. 
Surgery is delayed in order to allow intrinsic factors to be expressed. In 
order to maintain the treatment results IO is continued until 
intercuspation of the first deciduous molars. The duration of IO is also set 
by speech development. Objectives claimed by others are: less feeding 
problems; less danger of aspiration; keeping the tongue out of the cleft; a 
more normalized tongue tip function; restoring the symmetry of the 
maxilla; facilitation of lip surgery due to the narrowed cleft; straightening 
of the nasal septum; minimization of the severity of skeletal and dental 
deformities, thus less orthodontics and surgery later on; better speech 
development; psychological support for parents; psychological 
advantages for the child due to better child-parent interaction.42,44,45,61-68 
The proponents of NAM also claim a better and more predictable surgical 
outcome, less scar tissue formation, stable nasal change, better lip and 
nasal form, thus less surgical revisions, reduced need for alveolar 
bonegrafting and the treatment enables parents to actively participate in 
the habilitation of their child.69-71 Opponents, however, claim that IO is a 
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complex and expensive therapy while the claimed effects are not 
evidence based. It is also stated that maxillary growth is restricted 
artificially and that speech is negatively influenced because of the 
delayed surgery of the palate inherent to IO.52,72,73  
An attempt to perform a systematic literature review of the effect of 
IO revealed no evidence based information. This was mainly due to the 
fact that all studies lacked non treated contemporary (matched) controls 
as well as most studies lacked a complete description of the included 
patients or the performed treatments. Therefore this randomized 
prospective clinical trial was initiated. 
 
  
1.8 Research 
 
It is the challenge and aim of the cleft palate teams to render optimal 
treatment and to guard or improve the quality of life (QoL) of their 
patients while doing so. But what care is best, given the variations of 
CLP, their different expressions and severity? The best possible medical 
care should be effective and preferably evidence-based. Fifteen to twenty 
years ago it was concluded that cleft lip and palate surgery had become 
increasingly specialized and the results better and more uniform than in 
the past. New developments were likely to bring incremental rather than 
dramatic improvement.22 So far, historical case studies, case control 
studies and intercenter comparisons have elucidated some information 
about the used treatment protocols. Most interestingly it has been shown 
that centralization, experience and annual case load of the reconstructive 
surgeons appear to be most important in the prediction of the outcome.21 
This was also concluded from the Eurocleft study and stressed in the 
CSAG study.1,74-76 In 2002, however, the WHO concluded that treatment 
of craniofacial anomalies has escaped the rigors of health technology 
assessment, and that great confusion surrounds the optimal management 
of even the most common conditions like CLP. This is best demonstrated 
by the fact that in Europe 194 different protocols exist in over 201 cleft 
palate teams for the treatment of unilateral clefts.1  
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Resources and professional help are often limited and given a 
choice, the treatment should be cost-effective or in severe rare cases 
efficacious and worth the potential unwanted side-effects. The right 
attitude of the professionals to care, as well as good quality management 
of the CLP team organization are the only ways to assure and eventually 
improve quality of care delivered by a cleft palate team. Systematic 
registration of new cases, interventions and outcome is essential in order 
to be able to evaluate prevalence and treatment outcome assuring 
improvement of function, esthetics and QoL. Also a continuous 
improvement of quality of care should be strived at by implementing a 
quality improvement system.1  
 
 
1.9 Aims and outline of the clinical trial 
 
The aim of this clinical trial was to evaluate the effects of IO 
comprehensively using a contemporary research design. At the onset of 
this study IO was part of the treatment protocol for children born with 
UCLP in all three participating centers. Historically IO was introduced 
and implemented into the treatment protocol in all three centers by the 
same orthodontist. A detailed description of the experimental design, 
eligibility, treatment assignment, treatment protocol and operators can be 
found in chapter 2. The most important issues and specific information 
for each part of the study are given in each chapter separately. 
The following domains were evaluated: 
• general: feeding and nutritional status (chapter 4), satisfaction in 
motherhood (chapter 6) 
• orthodontic and surgical: development of the maxilla (chapter 2 and 
3), facilitation of surgical lip closure,77 facial appearance (chapter 5) 
• speech: prelexical development, phonological development, speech 
quality and intelligibility, and language development78  
• costs in relation to the effectiveness of the above mentioned domains 
(cost-effectiveness).77,79  
Each domain will provide relevant information on the effectiveness of 
IO. Integration of all aspects from each domain, however, is required to 
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reach an evidence based conclusion on infant orthopedics in children with 
complete unilateral cleft lip and palate. 
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Summary 
 
Aim of the study was to evaluate the effect of infant orthopedics (IO) on 
maxillary dimensions in infants with unilateral cleft lip and palate 
(UCLP). The study design was a prospective two-arm randomized 
controlled trial in parallel with three participating academic Cleft Palate 
Centers. Treatment was assigned by means of a computerized balanced 
allocation method. One group (IO
+
) wore passive maxillary plates during 
the first year of life, the other group (IO
-
) did not. Maxillary casts, made 
at birth, and at 15, 24, 48, 78 wk were digitized three dimensionally. 
Before lip closure alveolar, midpalatal and posterior cleft width reduced 
significantly more in IO
+
 than in IO
-
. After lip closure, the alveolar cleft 
width reduced significantly more in IO
-
. Until soft palate closure the 
slope of the palatal vault flattened significantly by IO. It is concluded 
that IO only has a temporary effect on maxillary arch dimensions that 
does not last beyond surgical soft palate closure. Therefore, infant 
orthopedics as a tool to improve maxillary arch form could be abandoned. 
However, other outcome variables like facial and dental appearance, 
speech outcome, and cost-effectiveness need to be investigated further in 
order to assess the comprehensive effect of infant orthopedics.  
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2.1 Introduction 
 
Since the introduction of infant orthopedics (IO) about half a century ago, 
IO has been part of the comprehensive care of cleft lip and palate patients 
in many cleft palate centers. In Europe in the year 2000 about 54% of the 
201 operational centers use infant orthopaedics.
1
 Infant orthopedics was 
developed and introduced on theoretical grounds, and it became part of 
the treatment protocol in many centers, although the actual effectiveness 
of IO had never been tested, nor were the possible adverse effects 
properly looked into.
1-4
 McNeil
5-6
 speculated on the possibility of 
molding the alveolar segments during the growth spurt in early infancy 
instead of puberty. His argument for IO was to actively align the 
segments to facilitate surgery.
5
 He also promoted the use of molding 
appliances after lip closure to control arch form and prevent collapse. 
Today’s main objective for IO7 has not really changed since McNeil, but 
more and more unsupported benefits were attributed to the treatment.  
Proponents of the use of infant orthopedics in UCLP, performed 
with passive acrylic plates from birth up to 18 months of age, have had a 
major influence, especially in Europe. Gnoinski
8
 stated in a review that 
this approach allows a more normalized pattern of deglutition, prevents 
twisting and dorsal position of the tongue in the cleft, improves arch form 
and position of the alar base, facilitates surgery, and improves outcome in 
general. Other advantages claimed in the literature are flattening of the 
palatal shelves, prevention of cross bites, straightening of the nasal 
septum, less danger of aspiration, better speech development, better nose 
breathing, better middle ear conditions, and additional psychological 
support for parents. Because of these positive effects, less speech therapy 
and orthodontic and surgical treatment is assumed to be needed in the 
long term (see among other studies
8-18
). 
Opponents of IO claim that infant orthopedics is a complex and 
expensive therapy and is not evidence based. Parents are obliged to travel 
frequently for treatment during the first year of the infant’s life and put 
up with the burden of compliance. Furthermore, maxillary growth is 
restricted artificially
3,19
 and speech is negatively influenced due to 
delayed surgery of the palate, inherent to IO.
20,21
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Most studies concerning IO are dealing with the effect on maxillary 
arch dimensions measured on dental casts.
8,15-17,19,22-24
 The results of these 
studies remain inconclusive due to shortcomings in the design of the 
studies. The most common shortcomings are retrospective study design, 
small sample size, lack of well described group characteristics like 
gender and type of cleft, lack of a (randomized) control group of UCLP 
children without IO, and lack of a proper description of the treatment 
itself. Also frequently no clear outcome measures are given, confounding 
variables are not taken into account, and competence of the professionals, 
who perform the treatment, is unclear.
25-27
 
To investigate the effect of IO in children with a complete UCLP, a 
prospective randomized trial started in 1993 in three academic Cleft 
Palate Centers in the Netherlands, i.e. the Cleft Palate Centers of 
Nijmegen, Amsterdam and Rotterdam. The primary objective of the study 
was to assess general effects (feeding, general body growth and parent’s 
satisfaction), orthodontic and surgical effects, and effects on speech. A 
comprehensive cost-effectiveness analysis at 4 yr of age will be part of 
the study. The part of the study reported here deals with the effects of IO 
(= IO
+
) and no IO (= IO
-
) on maxillary arch dimensions until 18 months 
of age. 
 
 
2.2 Material and methods 
 
2.2.1 Experimental design, eligibility and treatment allocation 
The experimental design was a prospective two-arm randomized 
controlled clinical trial in three participating academic cleft palate centers 
in the Netherlands: Nijmegen, Amsterdam and Rotterdam. The trial can 
be classified as a phase IV trial.
28
 The local Ethical Committees approved 
the study protocol. Sample size calculation was based on the detectable 
IO effect (3 deg) on the angle Sella-Nasion-Point A (SNA) at the age of 
4 yr. The minimum number of participants was calculated at 23 per 
group. 
The patient inclusion criteria were: complete UCLP, infants born at 
term, both parents Caucasian and fluent in the Dutch language and trial 
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entrance within 2 wk after birth. The exclusion criteria were: other 
congenital malformations (except for syndactily), and soft tissue bands. 
In each centre, the orthodontist and/or the plastic surgeon assessed 
eligibility. Parents of eligible infants were informed verbally about the 
trial, and written informed consent was obtained from all participants. 
A computerized balanced allocation method was used in order to 
reduce imbalance on relevant prognostic factors between groups. Patients 
were allocated based on birth weight (<3300 g or ≥3300 g) and alveolar 
cleft width (<8 mm, between 8 and 12 mm, or ≥ 12 mm). A computer 
program assigned the infant to the IO
+
 or IO
-
 group. Trial entrance was 
preferably within 2 wk after birth, and treatment started immediately 
after the allocation procedure. 
 
2.2.2 IO
+
 and IO
-
 treatment 
In order to standardize the treatment, all participating specialists joined 
consensus meetings. Consensus was reached on timing and type of the 
surgical interventions, and the surgeons standardized their surgical 
techniques. Lip surgery was performed at 18 wk of age according to the 
Millard technique. The soft palate was closed at the age of 52 wk 
according to a modified Von Langenbeck procedure. 
Infant orthopedics was performed by means of passive plates, 
starting within 2 wk after birth. The plate was fabricated on a plaster cast 
and consisted of compound soft and hard acrylic. The plate, with a small 
extension into the cleft nose, covered the palate and the alveolar ridges 
and obtruded the cleft in the hard and soft palate. The plate was placed in 
situ within a few days after the impression and worn 24 h a day, except 
for cleaning. It was held in situ mainly by suction and adhesion. If 
necessary, Corega® (Stafford-Miller Continental N.V., Hilversum, The 
Netherlands) was administered in order to improve retention. IO
+
 
children returned to the clinic every 3 wk to have their plates adjusted by 
grinding at the cleft margins to ensure proper approximation of the 
maxillary segments. Maxillary growth indicated the necessity for a new 
plate. Any broken or missing plate was repaired or replaced. After 
surgical lip closure, the plate was relieved in the frontal area and re-
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inserted the same day. Check-up visits were now planned every 4 to 6 
wk. The plate was worn until surgical closure of the soft palate.  
Children in the IO
-
 group did not wear plates. These infants visited 
the clinic for an extra check-up at the age of 6 wk as well as before and 
after lip repair and soft palate closure. 
 
2.2.3 Surgeons and orthodontists 
Each centre had one or two experienced surgeons to perform CLP 
surgery. The participating surgeons had 7 to 30 yr experience in CLP 
surgery. The three participating orthodontists had 6 to 28 yr experience 
with IO. The mean annual volume of children with clefts (including 
associated malformations) of each centre during the intake period (1993-
1996) was as follows: Nijmegen 56 infants, Amsterdam 25 infants, and 
Rotterdam 46 infants. Although it was aimed at to involve only 3 
surgeons, one in each centre, due to retirement and other circumstantial 
reasons the total number of surgeons turned out to be 7 (lip surgery), of 
whom 5 surgeons were involved in soft-palate surgery. The main team 
surgeons performed the majority (88%) of the operations. 
 
2.2.4 Data acquisition 
In order to evaluate the maxillary dimensions, impressions were taken at 
five different ages: within 2 wk after birth (T1), at 15 wk of age prior to 
surgical lip repair (T2), at 24 wk of age which is 6 wk after l ip repair 
(T3), at 48 wk of age which is 4 wk prior to soft palate closure (T4) and 
at 78 wk of age, which is half a year after soft palate closure (T5). The 
impressions were taken with an elastomeric material (Lastic®; 
Kettenbach Dental, Eschenburg, Germany), and plaster casts were then 
fabricated. 
The maxillary casts were analyzed three-dimensionally by means of 
the Reflex Microscope® (Reflex Measurement, Somerset, UK).
29,30
 
Eleven reference points as described by Shaw,
31
 as well as two additional 
reference points at the midpalatal cleft margins, were determined on the 
casts by one observer (CP), and the co-ordinates were digitized (Fig. 1).  
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Figure 1 Reference points and dimensions on the infant models. The definition of the 
landmarks and the used dimensions is as follows: 
 
T,T': tuberosity points, at the junction of the crest of the ridge with the outline of 
 the tuberosity. 
t,t': margins of the posterior cleft at the tuberosity points level. 
C,C': canine points, where a lateral sulcus crosses the crest of the alveolar ridge  
 (this corresponds to the top of the interdental papilla between canine and 
 first deciduous molar). 
Q,Q': gingival groove points, at the intersection of the gingival groove and the 
 lateral sulcus on the palatal side. 
I: incisal point, where a line connecting the incisal papilla and the labial 
 frenulum crosses the crest of the alveolar ridge (this corresponds to the top 
 of the inter-dental papilla between the central incisors). 
L': lesser segment margin, where the continuation of a line marking the crest of 
 the ridge turns from the oral side to the nasal side at the anterior end of the 
 segment. 
P': the same as for L' for the premaxillary segment. 
12: intersection of margin of the cleft at the cleft side and a line connecting 
 points C' and Q'. 
13: intersection of margin of the cleft at the non-cleft side and a line connecting 
 points C and Q. 
M: virtual point of which the co-ordinates are calculated by the computer 
 representing the midpoint of the line TT' 
P'L': alveolar cleft width, distance between point P' and L' 
CC': intercanine point distance, distance between point C and C' 
TT': intertuberosity point distance, distance between point T and T' 
I/CC': anterior arch depth, perpendicular from point I to line CC' 
<TMI: angle between point T, M and I 
<MTC: angle between point M, T and C 
<MT'C': angle between point M, T' and C' 
<13QQ': angle between point 13, Q and Q' 
<12Q'Q: angle between point 12, Q' and Q 
I/TT': total arch depth, perpendicular from point I to line TT'. 
1213: midpalatal cleft width, distance between point 12 and 13 
tt': posterior cleft width, distance between point t and t' 
Total arch length: calculated by adding the distances between the following points on the 
alveolar crest: T-C + C-I + I-P' and L'-C' + C'-T' 
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The reference points t and t´ can no longer be identified after surgical 
closure of the soft palate. Points P´ and L´ cannot be located when in 
contact with each other, then the value for cleft width P´L´ was set to 
0 mm. Therefore the number of measurements of the dimensions related, 
to P´ and/or L´ decreased in time. At the five different ages, 15 
dimensions were calculated as well as their increments between the ages.  
It is impossible to blind the orthodontist and the parents for 
treatment. It was tried to blind the surgeons by removing the plate prior 
to any surgical intervention, but it was unavoidable that the surgeons 
could recognize treatment if indentation of the plate was present in the 
palatal tissues. Data entry and analysis were blinded. The orthodontists 
who treated the patients did not assess the maxillary dimensions. 
 
2.2.5 Statistical analysis 
To assess the error of the landmark identification, casts of 10 subjects at 
three consecutive ages (n=30) were duplicated. One observer (CP) 
identified the landmarks on the original and the duplicated casts, with a 
4 months interval. Two observers digitized the landmarks. Mean 
measurement errors for dimensions and increments were assessed using 
Dahlberg’s formula. Reliabilities were calculated as Pearson’s correlation 
coefficients. 
Means and standard deviations were calculated for all dimensions at 
all ages and for increments between ages. Means and standard deviations 
of dimensions and increments were compared between groups with a 
Student’s t-test. Increments between ages were tested with a paired t-test. 
Treatment effects were tested on the following different primary and 
secondary outcomes: 
 Primary outcome 1: alveolar cleft width (P´L´) 
 Primary outcome 2: anterior arch depth (I/C´) and transverse 
dimensions (CC´, TT´) 
 Primary outcome 3: vertical slope of the palate (13QQ´ and 12Q´Q), 
position of the maxillary segments (MTC, MT´C´ and TMI) 
Secondary outcomes: total arch depth (I/TT´), IP´, L´C´ and total 
arch length, midpalatal cleft width (12-13) and posterior cleft width 
(tt´) 
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The effects were studied for changes over time from the start of the study 
T1 until T2 giving the initial treatment effect before lip closure, to T4 
(period of IO treatment) leading to the overall treatment effect, and to T5 
representing the medium long period effects. The increment T2-T3 
represents the immediate influence of lip surgery. Multiple comparison 
corrections were made in order to avoid false significant results. 
Bonferroni’s correction was applied per outcome type and per time 
interval as follows: 
 Primary outcome 1: tested at α = 0.05 
 Primary outcome 2: tested at α = 0.017 
 Primary outcome 3: tested at α = 0.01 
 Secondary outcomes: tested at α = 0.008 
The final hypothesis testing was done by analysis of covariance 
(ANCOVA), in which the final values at T2, T4 and T5 were explained 
by treatment (IO), correcting for the initial value of the corresponding 
variable, birth weight, the initial alveolar cleft width and centre effects. 
The relative influence of IO was expressed as the percentage of explained 
variance, calculated as the squared partial correlation coefficient 
correcting for the above mentioned co-variables. 
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2.3 Results 
 
2.3.1 General 
The intake started in January 1993 and ended in June 1996. In total, 54 
infants (41 boys, 13 girls) entered the trial, 27 in each group. A 
description of the sample characteristics is given in Table 1.  
 
Table 1 Overview of the sample, some variables are presented as percentiles, 
because of skewness i.e. P10, P50 (median) and P90. 
 
Sample characteristics IO- group IO+ group 
 N = 27 N = 27 
Female/Male 6/21 7/20 
Cleft left/right 18/9 17/10 
N centre 1/2/3 7/11/9 7/10/10 
Percentiles P10 P50 P90 P10 P50 P90 
Age at trial entrance (d)  1  6  13  0  3  7 
Birth weight (g)  2920  3600  4280  2660  3350  4020 
Alveolar cleft width at birth (mm)  8.6  12.4  16.4  9.5  12.5  14.4 
Age lip repair (d)  117  125  138  117  127  142 
Age soft palate repair (d)  301  367  389  355  375  438 
 
Fig. 2 shows the patient flow diagram through the study and reasons for 
non-evaluation. Two of the 27 IO
+
 patients hardly used the plates, and in 
one case the plate remained in situ for 78 wk by mistake. These infants 
remained in the IO
+
 group. During soft palate closure, additional lip 
corrections were performed in 13 children (IO
-
: n=5; and IO
+
: n=8). Two 
IO
+
 children had a second palatal operation due to dehiscence of the soft 
palate. Occasionally casts were missing (Table 2). Some reference points 
could not be digitized due to bad quality of the impression and were 
recorded as missing data. 
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Figure 2 Flowchart of patients through the trial and reasons for exclusion from 
evaluation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mean duration of IO was 50±16 wk. Mean number of visits was 
15.2±3.4, of which 7.9±1.3 visits were made prior to lip surgery. On 
average 2.7±1.0 plates were used. Mean number of visits in IO
-
 was 
5.8±0.9. After soft palate surgery both groups were monitored the same 
way. An overview of the surgical interventions and mean ages at which 
plaster casts were made is presented in Table 2. 
 
Randomisation N = 54 
Received IO as allocated, n = 27 
Appeared to be non-eligible after 
randomisation, n = 3 
 
Reasons: 
Simonart´s band, n = 1 
Incomplete cleft lip, n = 1 
Soft tissue band alveolus, n = 1 
Received non-IO as allocated, n = 27 
Appeared to be non-eligible after 
randomisation, n = 2 
 
Reasons: 
Simonart´s band, n = 1 
Submucous cleft of orbicularis oris 
muscle at opposite non cleft side, n = 1 
Evaluated in IO group for maxillary 
arch dimensions,  
n = 24 
Evaluated in non-IO group for maxillary 
arch dimensions,  
n = 25 
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Table 2 Overview of treatment interventions and mean ages in wk ± standard 
deviations (S.D.) at which plaster casts were made. N IO
-
, NIO
+
 and N total are the 
number of digitized plaster casts at a certain stage. T1-T5 are the different ages as 
referred to in the text. 
 
Time Age ± S.D. N IO- N IO+ N Total 
T1  0.3 ± 0.7 24 24 48 
T2  13.3 ± 2.0 25 22 47 
Lip-repair (18 wk) 
T3  22.7  ± 2.9 24 23 47 
T4  45.5 ± 4.8 24 22 46 
Soft palate repair; end of IO (52 wk) 
T5  75.3 ± 2.6 20 19 39 
 
 
Table 3 Mean intra-observer measurement errors (linear measurements in mm, 
angular measurements in degrees) and range of Pearson´s correlation coefficients 
(reliability %) of the evaluated dimensions at three ages and for two increments. 
Description of the different dimensions is given in Fig. 1 
 
Mean measurement 
error 
Reliability coefficient 
Range 
 Direct Increment Direct Increment 
 T1 T2 T3 T1 – T2 T1 T2 T3 T1 – T2 
Dimension  T1 – T3  T1 – T3 
P´L` 0.6 0.9 87-98 75-86 
CC´ 0.4 0.5 97-99 90-93 
TT´ 0.5 0.7 96-97 90-93 
I/CC´ 0.3 0.7 94-99 98-99 
<TMI 1.0 1.6 97-98 76-89 
<MTC 1.7 2.2 86-97 75-92 
<MT´C´ 1.2 1.8 80-97 69-92 
<13QQ´ 1.7 2.3 78-99 80-92 
12Q´Q 2.3 2.7 86-95 85-87 
I/TT´ 0.6 0.6 83-97 96-97 
12-13 0.5 0.7 92-97 80-91 
tt´ 0.3 0.3 98-99 86-99 
Arch length 1.5 1.6 90-97 75-88 
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2.3.2 Measurement error 
The intra-observer reliability for the different dimensions is presented in 
Table 3. The reliability coefficients were in the range of 69-99%, 
indicating that all measurements and increments had a sufficient 
reproducibility. 
 
2.3.3  Arch dimensions 
Mean values of the maxillary dimensions are presented in Table 4, while 
Table 5 shows the increments T1-T2, T2-T3, T1-T4 and T1-T5. The 
results of the tests on the effects of IO are given in Table 6. This table 
also shows the results of the ANCOVA. 
 
Cleft width: Alveolar cleft width (P´L´), which was one of the 
randomization criteria, did not differ significantly between both groups at 
birth. The mean alveolar cleft width was 12.3 mm in both groups. 
Between T1 and T2, the alveolar cleft width was reduced significantly in 
IO
+
 (P<0.001) but not in IO
-
 (P>0.1), resulting in a significant difference 
between groups (P<0.05). Between T2 and T3, P´L´ showed a significant 
reduction in both groups. However, the reduction was significantly less 
(P<0.001) for IO
+
 than for IO
-
. Later on, no significant differences were 
found in alveolar cleft width reduction. During the first time interval T1-
T2, the midpalatal cleft width reduction (12-13) was significantly 
(P<0.05) more in IO
+
=3.1±2.0 mm than in IO
-
=1.7±1.5 mm. The same 
was seen for the reduction of the posterior cleft width at the tuberosity 
level (tt´). For these two dimensions, no significant differences were 
found between groups after T2.  
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Table 4 Number (n), means and standard deviations of dimensions (in mm or deg) 
for groups IO
-
 and IO(
+
, grey). Follow-up is 78 wk 
 
 
Significance level: *0.05 ≥P>0.001;**0.01≥P>0.0001;***P≤0.001. 
 T1 T2 T3 T4 T5 
Time (n) mean (S.D.) (n) mean (S.D.) (n) Mean (S.D.) (n) mean (S.D.) (n) mean (S.D.) 
P'L' (24)  12.3  (3.1) (25)  11.7  (2.7) (20)  5.6  (2.5) (24)  3.8  (3.6)  (24)  2.6  (3.5) 
P'L' (23)  12.3  (1.7) (22)  10.6  (2.6) (19)  6.7  (2.7) (22)  3.1  (3.2)  (20)  2.0  (2.9) 
CC' (24)  32.7  (2.3) (25)  32.3  (2.6)* (24)  30.9  (2.3)* (24)  30.1  (2.5)  (20)  29.8 (3.0) 
CC' (24)  33.9  (1.9) (22)  34.1  (2.6) (23)  32.7  (3.1) (22)  31.8  (3.2)  (19)  30.3 (3.9) 
TT' (22)  33.4  (2.0) (23)  34.6  (2.0) (21)  34.4  (2.2) (21)  35.4  (2.4)  (18)  36.0 (3.0) 
TT' (23)  33.3  (1.9) (21)  33.9  (2.0) (21)  33.9  (2.6) (21)  34.6  (2.7)  (14)  34.5 (2.7) 
I/CC' (24)  9.3  (2.2) (25)  10.1  (2.1) (24)  7.8  (1.8)** (24)  8.7  (1.8)  (20)  9.8 (1.6) 
I/CC' (24)  8.4  (1.4) (22)  9.7  (0.9) (23)  9.1  (1.1) (22)  9.2  (1.5)  (19)  10.0 (1.7) 
<TMI (22)  74.7  (6.2) (23)  79.0  (5.5)* (21)  82.4  (4.9) (21)  86.1  (4.0)  (18)  87.4 (4.1) 
<TMI (23)  73.9  (3.8) (21)  75.8  (4.9) (21)  80.1  (5.3) (21)  83.9  (6.0)  (14)  86.7 (4.0) 
<MTC (22)  95.0  (5.4) (23)  91.4  (4.9)*** (21)  89.4  (4.0)* (21)  86.7  (4.5)*  (18)  86.2 (3.8) 
<MTC (23)  95.9  (3.7) (21)  96.3  (4.3) (21)  93.2  (6.6) (21)  90.8  (6.5)  (14)  87.6 (4.9) 
<MT'C' (22)  82.5  (3.9)** (23)  80.9  (5.0)* (21)  79.8  (4.1)* (21)  78.3  (4.1)  (18)  77.4 (5.1) 
<MT'C' (23)  86.0  (3.8) (21)  84.4  (5.0) (21)  83.0  (5.7) (21)  81.0  (4.5)  (14)  80.1 (5.7) 
<13 QQ' (23)  43.8  (6.3) (25)  45.0  (6.7)*** (18)  41.7  (8.6)* (19)  44.0  (7.8)**  (18)  38.5 (8.3) 
<13 QQ' (23)  43.6  (7.4) (22)  36.3  (6.6) (21)  35.1  (7.1) (21)  37.1  (5.2)  (19)  37.1 (6.0) 
<12Q'Q (23)  58.0  (7.1) (25)  62.0  (6.7)*** (18)  62.1 (5.3)*** (19)  61.4  (7.9)***  (18)  59.2 (6.6) 
<12Q'Q (24)  56.8  (6.4) (22)  51.9  (8.0) (21)  54.6  (6.6) (21)  52.9  (5.7)  (19)  57.7 (11.6) 
I/TT' (22)  25.9  (2.8) (23)  29.1  (2.3) (21)  27.6  (1.8) (21)  29.7  (1.6)  (18)  32.0 (2.4) 
I/TT' (23)  25.0  (1.9) (21)  28.0  (1.9) (21)  28.2  (2.1) (21)  29.8  (2.3)  (14)  32.0 (2.8) 
IP' (24)  8.4  (1.4) (25)  8.6  (1.3) (22)  9.3  (1.5) (21)  9.9  (1.5)  (17)  10.2 (1.8) 
IP' (24)  8.1  (1.5) (22)  9.2  (1.7) (22)  10.1  (1.4) (18)  10.8  (1.6)  (13)  10.6 (1.5) 
L'C' (24)  8.2  (1.3) (25)  8.9  (1.5)* (23)  9.2  (1.7) (20)  9.4  (1.6)  (13)  10.3 (2.2) 
L'C' (24)  8.5  (1.5) (22)  9.8  (1.3) (22)  9.7  (1.4) (16)  9.9  (1.5)  (10)  10.2 (2.0) 
1213 (23)  15.5  (1.7) (25)  13.8  (2.1) (17)  12.1  (2.5) (19)  10.3  (2.4)  (18)  6.9 (2.9) 
1213 (23)  15.8  (2.1) (22)  12.8  (2.4) (21)  10.9  (2.9) (21)  9.0  (2.9)  (19)  6.9 (2.2) 
tt' (21)  13.6  (1.8) (21)  12.4  (2.1) (17)  12.2  (2.3) (14)  11.3  (2.4)   -  
tt' (20)  13.8  (2.0) (21)  11.7  (1.7) (21)  11.2  (2.6) (22)  10.0  (2.4)   -  
Archlength (22)  65.5  (5.6) (23)  72.6  (4.8) (18)  73.6  (4.4) (16)  79.1  (4.5)  (12)  82.0 (4.4) 
Archlength (23)  64.5  (3.4) (21)  71.7  (4.5) (21)  74.5  (4.1) (15)  79.5  (4.9)  (7)  82.9 (6.6) 
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Linear arch dimensions: In both groups, anterior arch width CC´ 
decreased over time (T1-T5). The tuberosity width TT´ increased 
significantly in IO
-
 from T1 to T5 but not in IO
+
. However, over the 
entire experimental period, the mean values for this increment did not 
differ significantly between groups.  
Anterior arch depth (I/CC´) increased significantly (P<0.05) more in 
IO
+
=1.7±1.7 mm than in IO
-
 =0.1±1.7 mm between T1 and T5. After lip 
closure, a reduction was seen of this dimension in both groups, but 
significantly more in IO
-
 than in IO
+
. The same was seen for total arch 
depth (I/TT´). For total arch length no differences between groups were 
found. From T1 to T5, mean growth at the alveolar cleft margins 
represented by IP´ and L´C´ was up to 2 mm on each side (IP´ and L´C´ 
are part of the calculation of the total arch length). During the first 
increment period, however, the increases of IP´ and L´C´ were larger in 
IO
+
 than in IO
-
 (P<0.001 and P<0.05, respectively).  
 
Angular measurements: The inclination of the smaller segment to the line 
TT´, represented by angle MT´C´, was the only dimension to differ 
significantly (P<0.01) between groups at intake. This difference 
neutralized with time. The contra-lateral angle MTC did not differ at 
intake, but was reduced significantly (P<0.001) more in IO
-
 before lip 
closure. At T2, T3 and T4, a significant difference between groups was 
seen, which was no longer present at T5. 
The slope of the mid palate, represented by the angles 12Q´Q and 
13QQ´, increased in IO
-
 and decreased in IO
+
 from T1 to T2. During the 
experimental period T1-T4, a significant flattening of the midpalatal 
slope was seen in IO
+
, which was no longer present at T5. At T5 no 
differences were found between groups. 
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Table 5 Number (n), means and standard deviations of increments of the dimensions 
(in mm or deg) for groups IO
-
 and IO(
+
, grey) 
 
 T1-T2 T2-T3 T1-T4 T1-T5 
Increments (n) mean (S.D.) (n) mean (S.D.) (n) mean (S.D.) (n) mean (S.D.) 
P'L' (24)  -0.6  (2.2)* (20)  -6.3  (1.9)** (23)  -8.3  (4.2)  (23)  -9.7  (3.8) 
P'L' (22)  -1.9  (2.1) (18)  -4.3  (2.0) (22)  -9.2  (2.9)  (20) -10.4  (2.9) 
CC' (24)  -0.5  (1.8) (24)  -1.3  (1.5) (23)  -2.5  (2.2)  (19)  -2.5  (2.5) 
CC' (22)  0.3  (2.1) (21)  -1.5 (1.30) (22)  -2.0  (2.9)  (19)  -3.8  (4.2) 
TT' (21)  1.1  (1.4) (21)  -0.2  (1.3) (19)  1.7  (1.8)  (15)  2.9  (2.9) 
TT' (20)  0.4  (1.7) (19)  0.1  (1.8) (20)  1.1  (2.7)  (13)  0.7  (3.1) 
I/CC' (24)  0.7  (0.8)* (24)  -2.1  (1.1)*** (23)  -0.7  (1.4)**  (19)  0.1  (1.7)** 
I/CC' (22)  1.5  (1.1) (21)  -0.8  (0.7) (22)  0.7  (1.8)  (19)  1.7  (1.7) 
<TMI (21)  4.5  (4.5) (21)  3.8  (3.1) (19)  10.6  (5.2)  (15)  12.4  (5.0) 
<TMI (20)  2.5  (3.1) (19)  4.3  (3.4) (20)  9.7  (4.7)  (13)  12.6  (4.9) 
<MTC (21)  -3.5  (4.8)** (21)  -2.3  (3.3) (19)  -7.8  (4.4)  (15)  -9.0  (4.7) 
<MTC (20)  0.8  (3.9) (19)  -3.5  (3.8) (20)  -5.2  (5.8)  (13)  -8.3  (6.3) 
<MT'C' (21)  -0.7  (3.5) (21)  -0.9  (3.8) (19)  -3.5  (3.4)  (15)  -4.0  (2.9) 
<MT'C' (20)  -1.4  (4.2) (19)  -1.5  (3.7) (20)  -4.5  (4.6)  (13)  -5.8  (4.3) 
<13 QQ' (23)  1.1  (4.7)*** (18)  -2.6  (6.1) (17)  -0.5  (5.8)**  (16)  -4.5  (7.3) 
<13 QQ' (21)  -7.5  (5.7) (20)  -1.5  (5.1) (20)  -5.8  (5.6)  (19)  -6.7  (8.0) 
<12Q'Q (23)  4.2  (7.6)** (18)  1.8  (4.5) (17)  3.8  (8.1)**  (16)  1.2  (8.0) 
<12Q'Q (22)  -4.8 (10.4) (20)  2.0  (5.5) (21)  -3.3  (7.6)  (19)  1.5 (13.1) 
I/TT' (21)  3.1  (1.6) (21)  -1.2  (1.4)** (19)  3.5  (2.4)  (15)  5.9  (2.9) 
I/TT' (20)  3.2  (2.2) (19)  0.1  (1.4) (20)  4.5  (2.6)  (13)  6.5  (2.5) 
IP' (24)  0.1  (0.8)*** (22)  0.9  (1.1) (20)  1.6  (1.0)*  (16)  2.2  (1.0) 
IP' (22)  1.1  (1.0) (21)  0.8  (1.1) (18)  2.6  (1.3)  (13)  2.7  (1.3) 
L'C' (24)  0.7  (0.8)* (23)  0.4  (0.7)* (19)  1.3  (1.0)  (12)  2.0  (1.7) 
L'C' (22)  1.3  (0.9) (21)  -0.2  (1.0) (16)  1.6  (1.0)  (10)  1.9  (1.2) 
1213 (23)  -1.7  (1.5)* (17)  -1.4  (1.1) (17)  -5.0  (2.3)  (16)  -8.0  (3.5) 
1213 (21)  -3.1  (2.0) (20)  -1.9  (1.3) (20)  -6.5  (2.9)  (19)  -8.8  (2.7) 
tt' (19)  -0.9  (1.4)* (16)  -0.1  (1.3) (14)  -2.6  (1.7)  -  
tt' (17)  -2.3  (1.9) (19)  -0.5  (1.4) (18)  -3.7  (2.4)  -  
Archlength (21)  7.1  (3.1) (18)  2.5  (2.7) (15)  14.6  (4.7)  (9)  19.1  (4.5) 
Archlength (20)  7.6  (3.5) (19)  2.9  (2.5) (14)  15.1  (4.2)  (6)  17.5  (4.7) 
 
Significance level: *0.05≥P>0.01; **0.01≥P>0.001; ***P≤0.001. 
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Table 6 Mean treatment effect (eff), standard error (SE) and explained variance by 
treatment (r sq) corrected for initial cleft width and centre for three increments. Effects 
are measured in mm or deg. explained variance as percentage. 
 
 T1-T2 T1-T4 T1-T5 
Increments eff SE r sq eff SE r sq Eff SE r sq 
P'L'  -1.2 (0.6)   10*  -1.0 (1.0)  5   -  
CC'   0.9 (0.6)  6  0.4 (0.8)  1  -1.3 (1.4)  3 
TT'   -0.8 (0.4)  10  -0.7 (0.7)  3  -1.8 (1.1)  10 
I/CC'  0.6 (0.3)  9  0.8 (0.4)  10  0.9 (0.5)  10 
<TMI  -2.4 (1.1)  12  -1.7 (1.5)  4  -0.2 (1.5)  0 
<MTC  5.1 (1.2)  36  3.4 (1.7)  11  1.9 (1.9)  5 
<MT'C'  -0.1 (1.3)  0  -0.8 (1.2)  1  -1.5 (1.7)  4 
<13 QQ'  -8.3 (1.4)  49  -5.5 (1.6)   25**  -2.4 (2.4)  3 
<12Q'Q -10.4 (2.1)  38  -9.1 (2.1)   38***  -2.7 (3.5)  2 
I/TT'  0.1 (0.5)  0  0.6 (0.6)  2  0.6 (1.0)  2 
IP'  0.9 (0.3)  24  0.9 (0.4)  15   -   
L'C'  0.6 (0.2)  15  0.3 (0.3)  4   -  
12-13  -1.4 (0.5)  17  -1.6 (0.8)  11  -0.5 (0.9)  1 
tt'   -1.3 (0.5)  18  -1.3 (0.8)  10   -   
Archlength  0.5 (0.9)  1  0.1 (1.6)  0  -   
 
Significance level: *P<0.05; **P<0.01; ***P<0.001 (Bonferroni corrections applied).  
- =calculations not possible or not performed. 
 
 
2.4 Discussion 
 
In order to compensate for shortcomings of earlier studies, the design 
chosen for this study was a prospective two-arm randomized controlled 
trial in parallel with three participating academic cleft palate centers. 
Possible effects of the IO treatment were analyzed with ANCOVA  
(Table 6) for the different outcomes at the chosen time points T2, T4 and 
T5 and not by direct t-test on the outcomes and their increments (Tables 
4,5). It was considered necessary to control for the co-variables “centre”, 
“birth weight” and “initial alveolar cleft width”. This was not meant to 
correct for confounding, which is not substantial in a balanced clinical 
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trial, but to reduce the noise in the outcome; centre and alveolar cleft 
width may explain a considerable part of the variance in the outcome, 
leading to a low residual variance and, by consequence, to narrow 95% 
confidence intervals (CI) for the treatment effect. The (inefficient) 
analysis of increments, which are known to include the measurement 
error twice, was avoided by entering the corresponding initial value of 
the studied outcome in the same ANCOVA. In this way, the performed 
ANCOVA will generally lead to the most efficient estimates of the IO 
treatment effects. 
In terms of treatment effect, the sole attribute of IO was only 
expressed in the period prior to lip closure. Type and timing of the 
surgical interventions were kept the same for both groups, because 
differences could interfere with the outcome of IO. In both groups, the 
alveolar cleft width reduction prior to lip surgery was relatively small 
when compared to the reduction induced by surgical lip closure (T2-T3). 
The percentage explained variance of IO during T1-T2 was 10, during 
T1-T4 it dropped to 5. The alveolar cleft width was reduced, while the 
dimensions IP´ and LC´ at the cleft margins increased in the IO
+
 group. 
This means that initial reduction of the alveolar cleft could be due to 
approximation of the segments, but also to hypertrophy of the soft tissues 
at the cleft margins as a result of wearing the plate. This tissue excess 
may disappear after lip closure, when the plate is reduced in the labial 
part to allow for molding of the maxillary segments by the reconstructed 
lip. The findings of Mishima et al.
32
 support this hypothesis. Therefore, 
reduction of the alveolar cleft width cannot be considered as a 
representative variable for the effect of IO. The midpalatal and the 
posterior cleft width differed between groups prior to lip closure; the 
explained variance was 17% and 18%, respectively. Later on, no 
significant differences were seen, and the influence of treatment 
diminished furthermore. The larger segment was aligned more towards 
the virtual correct midline before lip closure, but this difference 
disappeared after lip closure. 
Infant orthopedics seems to have a significant temporary effect on 
the shape of the palatal vault. When IO was used, the palatal vault 
flattened. The percentages of explained variance of IO for the angles 
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13QQ´ and 12Q´Q were up to 49% and 38%, respectively, the highest of 
all dimensions. An explanation for this finding could be that during IO 
(T1-T4) the tongue is kept out of the cleft, allowing the palatal shelves to 
flatten in the treated group. Once the soft palate was operated upon, the 
effect of treatment disappeared, and at 78 wk the shape of the palatal 
vault was comparable for both groups.  
In the Dutchcleft study, the number of visits and plates used in the 
IO
+
 group and the maxillary dimensions were comparable to the findings 
of Gnoinski
8
. Initial alveolar cleft width of the IO
+
 group in the 
Dutchcleft study was 12.3±3.1 mm and in the Gnoinski group 12.0±3.3 
mm. Initial palatal cleft width was 15.8±2.1 mm in the Dutchcleft study 
and 14.0±3.4 mm in the Gnoinski group. At the age of 18 months, the 
mean value for the palatal cleft width was 6.9±2.2 mm for the IO
+
 group 
of the Dutchcleft study. In the group of Gnoinski, a mean width was 
found of 7.7±2.4 mm, but the soft palate was not closed yet at the age of 
18 months, whereas the soft palate in the Dutchcleft study was closed at 
the age of 12 months. Unfortunately, the Zurich CLP centre never 
published the results of a comparative randomized study comparing the 
two treatment options. 
Kramer et al.
19,23,24
 reported maxillary dimensions of UCLP patients 
treated with IO. In these studies, the IO treatment protocol was very 
similar to that of the present study. Although no non-treated control 
group was used, Kramer et al. warranted that IO restricts transverse 
maxillary growth before lip closure,
17
 and that the plate prevents palatal 
collapse immediately after lip closure.
23
 The results from the Dutchcleft 
study do not support this conclusion. Our results partially agree with the 
results of the study of Mishima et al.
15-17
 Before lip repair, comparable 
effects were found with respect to the position of the maxillary segments 
and the shape of the palatal vault.
15
 In the study of Mishima al., the soft 
palate was closed at 18 months. At 18 months of age, they found four 
specific effects in the IO
+
 group as compared to the IO
-
 group:
 
(1) the 
transverse palatal width was larger;
 
(2) the sagittal gap between the two 
segments was smaller (distance P´L´ projected on a perpendicular from 
point I on a line through TT´);
 
(3) the palatal vault was more flattened; 
and
 
(4) the migration of the lesser segment towards the major segment 
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was larger. Mishima et al. concluded that, therefore, the palates were 
larger in the IO
+
 group.
16
 At 4 yr of age,
17
 the same children were 
evaluated again and two effects were still present in the IO
+
 group: the 
transverse palatal width remained larger, and the palatal vault remained 
flattened. In the Dutchcleft study, maxillary segments significantly 
moved towards each other in both groups, and differences in the slope of 
the palatal shelves, although not measured the same way, did not last 
post-IO. The size of the palates was the same in both groups. The 
differences between the two studies may be attributed to the non-
randomized design and small sample size of the Mishima studies as well 
as racial differences, different treatment protocols, and different 
measurement methods. 
From the results of the present study it is concluded that infant 
orthopedics only has a temporary effect on maxillary arch dimensions 
that does not last beyond surgical soft palate closure. Therefore, infant 
orthopedics as a tool to improve maxillary arch form could be abandoned. 
However, other outcome variables, like oral function, facial and dental 
appearance, speech outcome,
33,34
 and costs
35
 need to be investigated 
further. A follow-up and an interdisciplinary cost-effectiveness analysis 
are planned at 4 yr of age in order to assess the comprehensive effect of 
infant orthopedics. 
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Summary 
 
Objective: To study the effect of infant orthopedics (IO) on maxillary 
arch form and position of the alveolar segments. 
Design: Prospective two-arm randomized, controlled trial in parallel 
with three participating academic cleft palate centers. Treatment was 
assigned by means of a computerized balanced allocation method. 
Setting: Cleft palate centers of Amsterdam, Nijmegen, and 
Rotterdam, the Netherlands. 
Patients, Participants: Infants with complete unilateral cleft lip and 
palate and no other malformations. 
Interventions: One group (IO
+
) wore passive maxillary plates during 
the first year of life; the other group (IO
-
) did not. All other interventions 
were the same. 
Main Outcome Measure(s): The presence of contact and/or overlap 
(collapse) between the maxillary segments at maxillary casts made 
shortly after birth, at 15, 24, 48, 58, and 78 weeks. Survival experience of 
contact and collapse with time as well as the frequencies of different arch 
forms and severity of collapse were evaluated. 
Results: Comparable arch forms with no contact or overlap of the 
maxillary segments were seen at birth in both groups. With time the 
frequency of collapse increased, with no significant differences between 
groups. No significant group differences were found with respect to the 
survival experience of contact and collapse or for the severity of collapse 
at the end of the observational period. 
Conclusions: Infant orthopedics does not prevent collapse and can be 
abandoned as a tool to improve maxillary arch form. 
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3.1 Introduction 
 
Maxillary arch form in patients with complete unilateral cleft lip and 
palate (UCLP) changes substantially during in-fancy as a result of 
treatment and growth.
1-9
 The anterior alveolar arch width narrows with 
time, accelerated by surgical closure of the lip and palate. Unfortunately, 
the arch form narrows in many cases to the extent that the alveolar 
segments overlap each other in the transversal direction (collapse) to a 
greater degree than would be considered ideal ridge relationship.
10
 The 
major concern with the collapsed arch forms is the development of 
crossbite in the deciduous and permanent dentition. 
Even though infants with complete UCLP show a certain variety of 
arch forms and dimensions, this group rarely shows collapse of the 
maxillary segments at birth. Bacher et al.
11
 showed that at birth the 
proximal end of the major segment at the cleft side was always anterior to 
the minor segment, no overlap of the segments occurred, and the 
midpoint of the premaxilla was shifted to the cleft side. Kramer et al.
2
 
showed that patients with UCLP initially demonstrated larger anterior 
and posterior arch width and arch depth dimensions than the noncleft 
population. These differences were reversed when compared with 
noncleft individuals at 18 months. In general, treated patients with UCLP 
have a smaller maxillary arch width and higher prevalence of lateral and 
anterior crossbites, compared with the noncleft population. For some cleft 
palate centers, this is one of the objectives leading to the inclusion of 
infant orthopedics (IO) into their treatment protocols, to prevent the 
occurrence and severity of collapsed arch forms.
12,13
 
Only a few studies have evaluated the effects of IO on maxillary 
arch form using passive plates on maxillary arch form.
5-7,14
 None, 
however, have compared the effects of IO on maxillary arch form in a 
randomized controlled trial. Mazaheri et al.
10
 qualitatively studied the 
change of arch form in patients with UCLP in an observational study. It 
was their view that good arch form could be achieved without additional 
therapeutic interventions like IO. They found that at the age of 1 month, 
50% of the children presented overlap (collapse) of the alveolar 
segments. This percentage increased with time to reach 80% at the age of 
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18 months and decreased to 50% at the age of 4 years. Supporters of IO,   
5-8,12,13,15,16
 using passive acrylic plates, claimed that the treatment molds 
the alveolar segments into a better arch form and prevents collapse, 
improving dentomaxillary development. However, little research has 
been conducted to ascertain whether this holds true or to elucidate what 
the desired arch form should be at different stages or ages to achieve 
optimal results in later life. It is generally assumed that a noncollapsed 
arch form during infancy is a reasonable starting point for normalized 
dental and skeletal development. 
To investigate the effect of IO in children with a complete UCLP, a 
prospective randomized trial was initiated in 1993 in three academic cleft 
palate centers in the Netherlands (i.e., the cleft palate centers of 
Nijmegen, Amsterdam, and Rotterdam). The primary objective of the 
study was to assess general effects (feeding, general body growth, and 
parents’ satisfaction), orthodontic and surgical effects, and effects on 
speech. A comprehensive cost-effectiveness analysis at 4 years of age 
was part of the study. The portion of the larger study reported here deals 
with the effects of IO (IO
+
) versus no IO treatment (IO
-
) on maxillary 
arch form and the position of the maxillary segments in children with 
UCLP until 18 months of age. 
The hypotheses to be tested were whether the first contact between 
the maxillary alveolar segments is reached earlier and the frequency of 
contact is higher, when IO is used; whether IO prevents collapse of the 
maxillary alveolar segments; and, in case of collapse, whether severity of 
the collapse is reduced by IO. 
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3.2 Materials and methods 
 
A detailed description of the trial (Dutchcleft) with respect to 
experimental design, eligibility and treatment assignment, treatment 
protocol, and operators can be found in a previous publication.
9
 
 
3.2.1 Experimental design 
The experimental design was a prospective two-arm randomized, 
controlled clinical trial in three academic cleft palate centers in the 
Netherlands: Nijmegen, Amsterdam and Rotterdam. The local ethical 
committees approved the study protocol. The inclusion criteria were 
complete UCLP, infants born at term, both parents Caucasian and fluent 
in the Dutch language, and trial entrance within 2 weeks after birth. The 
exclusion criteria included soft tissue bands and other congenital 
malformations (except syndactyly). Between 3 and 6 months of age, all 
included children were checked by the geneticist of their own cleft lip 
and palate (CLP) team as being nonsyndromic.  
 
3.2.2 IO
+
 and IO
-
 treatment 
IO was performed by means of passive plates, starting within 2 weeks 
after birth. The plate was fabricated on a plaster cast and consisted of 
compound soft and hard acrylic. 
IO
+
 children visited the clinic every 3 weeks to have their plates 
adjusted by grinding the cleft margins to ensure proper approximation of 
the maxillary segments. Maxillary growth indicated the necessity to make 
a new plate. After surgical lip closure, the plate was relieved in the lip 
region and reinserted the same day. Check-up visits were then planned 
every 4 to 6 weeks. The plate was maintained until surgical soft palate 
closure. 
Children in the IO
-
 group did not wear plates. These infants visited 
the clinic for an extra check-up at the age of 6 weeks as well as before 
and after lip surgery and soft palate closure.  
In both groups, lip surgery was performed at about 18 weeks of age 
using the Millard technique, and soft palate closure was performed at the 
age of about 52 weeks using a modified Von Langenbeck procedure.  
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3.2.3 Data acquisition 
To evaluate the maxillary dimensions, impressions were taken at six 
different ages: T1, within 2 weeks after birth; T2, at 15 weeks of age 
(prior to surgical lip repair); T3, at 24 weeks of age (6 weeks after lip 
repair), T4; at 48 weeks (4 weeks prior to soft palate closure); T5, at 
58 weeks (approximately 6 weeks after soft palate repair); and T6, at 
78 weeks (6 months after soft palate closure). The impressions were 
taken with an elastomeric material (Lastic, Kettenbach Dental, 
Eschenburg, Germany), and plaster casts were then fabricated. 
Initially casts at T6 were examined and the presence of contact as 
well as collapse of the alveolar segments scored. Contact was scored as 
absent (score=0) or present (score=1), and collapse was scored as absent 
(score=0), slight (score=1), moderate (score=2), or severe (score=3). Five 
independent observers, all orthodontists specialized in CLP care who 
were not directly involved in the trial, scored the casts twice. 
Subsequently, all models at all previous stages (T1 through T5) were then 
evaluated by one of the five observers, scoring the presence of contact 
and collapse. Scoring and data entry were performed blinded for 
treatment. With the results of the scoring for presence or absence of 
contact and collapse, the individual patients were categorized into 4 arch 
forms, comparable to Mazaheri et al.
10
 In addition, the severity of 
collapse was evaluated at T6. 
 
3.2.4 Statistical analysis 
Intraobserver agreement (kappa) and the interobserver agreement 
(correlation coefficient) were calculated for the scoring of contact and 
collapse of the alveolar segments at T6. The overall reliability was 
calculated (Cronbach alpha) for contact, collapse, and severity of 
collapse. In combination with the results at T1 through T5, actuarial 
survival curves of contact and collapse were calculated to evaluate the 
percentage of patients surviving contact and collapse in time. The actual 
ages at which the impressions were taken were used to construct the 
curves. The final hypothesis testing was done by comparison of the 
survival experience in both groups with the Gehan statistics. Frequencies 
of the different arch forms from T1 to T6 were calculated and presented 
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in cross tables, differences between groups tested with chi square 
statistic, and possible center effects were tested by means of an analysis 
of variance (ANOVA). The severity scores of collapse at T5 and T6 were 
evaluated by means of a Student’ t test. Specific center effects on the 
outcome were tested by means of an ANOVA. All tests were based on a 
probable error of p <.05. 
 
 
3.3 Results 
 
3.3.1 General 
Between January 1993 and June 1996, a total of 54 infants (41 boys, 13 
girls) entered the trial, with 27 in each group. A description of the sample 
characteristics, patient flow diagram through the study, and reasons for 
nonevaluation has been published elsewhere.
9
 
Casts of six different ages were available from 49 patients, 24 IO
+
 
and 25 IO
-
. Occasionally casts were missing (Table 1). Therefore, the 
moment of contact was not precisely known for six patients, and in these 
cases it was randomly chosen for the early or late moment. The same was 
done in seven patients for the moment of collapse. In two patients casts 
were missing at T5 and T6 and at T4, T5, and T6, respectively, and the 
missing data were recorded as missing values. These imputations were 
used only to calculate the frequencies of different arch forms and severity 
of collapse. When calculating the actuarial survival curves for hypotheses 
testing, the nonimputed data were used. 
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Table 1 Overview of Treatment Interventions and Mean Ages in wk ± SD at Which 
Plaster Cast Were Made* 
 
Time Age ± S.D. IO
-
 
N  
IO
+
 
N 
T1  0.3 ± 0.7 24 24 
T2  13.3 ± 2.0 25 22 
Lip repair (18 wk) 
T3  22.7  ± 2.9 24 23 
T4  45.5 ± 4.8 24 22 
Soft palate repair, end of IO (52 wk) 
T5  57.7 ± 3.1 22 16 
T6  75.3 ± 2.6 20 19 
 
* N IO
-
, N IO
+
, and N total are the number of digitized plaster casts at a certain stage. T1-T6 are the 
different ages as referred to in the text. IO = infant orthopedics. 
 
3.3.2 Measurement error 
The intraobserver reliability for scoring contact and collapse was 
moderate to high (kappa 5 0.84 and 0.63, respectively). The interobserver 
agreement (Pearson’s correlation coefficients) for contact was in the 
range of 0.92 to 0.97, collapse in the range of 0.66 to 0.85, and severity 
of collapse 0.80 to 0.91. The overall reliability range (Cronbach alpha) 
for the judgment of contact, collapse, and severity of collapse was 0.92 to 
0.98. These outcomes indicated that all measurements had a sufficient 
reproducibility (minimum correlation was set at 0.70) and reliability 
(minimum a was set at 0.7). 
 
3.3.3 Arch form 
Frequencies (in percentages) of the different relationships of the alveolar 
segments at the age of 1½ years are presented in Table 2. Prior to surgical 
lip closure in both groups, no patients showed contact between the 
alveolar segments. At the age of 1½ years, more than half of the patients 
in both groups demonstrated contact between the segments. Chi square 
statistics showed no significant differences between groups. The actuarial 
contact survival curves for both groups are presented in Figure 1. The 
results of the Gehan statistics comparing the curves of the two groups 
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showed that there were no significant differences in surviving experience 
between groups.  
 
Table 2 Number of infant and percentages of the different arch forms for both groups 
IO
-
 and IO
+
 (grey) at Six Ages* 
 
 
* Maxillary arch form: no contact and no overlap (NC-NO), no contact and overlap (NC-O), contact and no 
overlap (C-NO), contact and overlap (C-O), number (n) and percentages (%) of infants concerned. T1-T6 
are the different ages as referred to in the text. IO = infant orthopedics. 
 
 
Figure 1 Actuarial survival curves of no contact until 78 weeks of age. 
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)  24 (100) 
 
 24 (100) 
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-
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Overlap of the alveolar segments had occurred in one patient before lip 
closure, and with time the total number of patients increased. At 1½ years 
of age, half of the patients showed overlap of the segments, but chi 
square statistics showed no significant differences between the groups. 
Moderate collapse occurred first at T4, and severe collapse was first 
diagnosed at T6. The mean severity scores for collapse at T5 were 
IO
+
=0.4 (SD=0.6) and IO
-
=0.6 (SD=0.7). At T6 these values had 
increased to IO
+
=0.6 (SD=0.7) and IO
-
=1.0 (SD=0.9). No significant 
differences were found for the severity scores at T5 and T6 (Student’s t 
test, p=.18 and p=.12, respectively). The actuarial collapse survival 
curves for both groups are presented in Figure 2. Gehan statistics 
comparing the curves of the two groups showed that there were no 
significant differences between the surviving experience of the two 
groups. 
ANOVA showed that there were no significant interactions between 
outcome measures and cleft palate center or surgeon. 
 
 
Figure 2 Actuarial survival curves of no collapse until 78 weeks of age 
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3.4 Discussion 
 
Since the introduction of IO about half a century ago, it has been part of 
the comprehensive care of patients with CLP in many cleft palate centers. 
In Europe in 2000, about 54% of the 201 operational centers use IO.
17
 IO 
was developed and introduced on theoretical grounds, and it became part 
of the treatment protocol in many centers, although the actual 
effectiveness of IO had neither been tested nor the possible  adverse 
effects properly evaluated.
17-20
 To compensate for shortcomings of earlier 
studies, the design chosen for the present study was a prospective two-
arm randomized, controlled trial in parallel with three academic cleft 
palate centers.
9
 This trial is ongoing, but early reports on the effects of IO 
on maxillary arch dimensions
9
 and speech
21,22
 as well as the cost-
effectiveness of the procedure
23
 have already been published. The present 
report deals with maxillary arch form. A qualitative method was used to 
assess contact, overlap, or both of the maxillary segments. The 
assessment, performed by orthodontists experienced in CLP care, proved 
to be reliable. Whether the method is reliable when applied by 
orthodontists not experienced in CLP treatment is not known. 
Until now actuarial survival curves to describe maxillary segment 
contact, overlap, or both over time were never used in other studies. The 
curves showed that at birth in 100% of the patients, the maxillary 
segments were not in contact or overlap position. However, this 
percentage decreased steadily until the end of the observation period at 
18 months of age, irrespective of the treatment received. 
Comparing the results in both groups of the Dutchcleft study with 
the results of Mazaheri et al.,
10
 the findings showed similarities as well as 
differences in spite of different treatment protocols. No contact was seen 
before lip closure in both groups in the Dutchcleft study, whereas 
Mazaheri et al.
10
 reported contact in about 40% of the patients as early as 
1 month of age. Also, the percentage of collapse was relatively higher 
and occurred sooner than in the Dutchcleft study. These differences could 
be due to different clinical views on contact or collapse and differences 
between the surgical protocols. In the Mazaheri et al.
10
 group, lip closure 
by means of a Rose-Thompson operation with a small triangular flap 
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above the vermilion border was performed at the mean age of 3.3 months. 
A two-stage palatal repair was performed consisting of a vomer flap at 
the mean age of 13.7 months and a soft palate repair at 16.6 months. 
Statements by Kramer et al.
4
 that IO restricts growth in the transverse 
direction and those by Opitz and Kratzsch
8
 that wearing an orthopedic 
plate after lip surgery actually prevents collapse in the anterior region 
could not be supported. 
From the findings of the Dutchcleft study, it can be concluded that 
IO in patients with UCLP did not facilitate initial contact between the 
maxillary segments, nor did it prevent collapse of the alveolar segments. 
Furthermore, IO had no positive effect on the severity of collapse from 
birth until the age of 18 months. Based on these results, it was concluded 
that IO had no significant effect and that this treatment as a tool to 
prevent maxillary arch collapse could be discarded. However, the long-
term results of other outcome variables such as oral function, facial and 
dental appearance, speech outcome, and costs are being investigated to 
assess the comprehensive cost effectiveness of IO. 
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Summary 
 
Objective: To study the effects of infant orthopedics (IO) on feeding, 
weight, and length. 
Design: Prospective two-arm randomized controlled trial in three 
academic Cleft Palate Centers. Treatment allocation was concealed and 
performed by means of a computerized balanced allocation method. 
Setting: Cleft Palate Centers of Amsterdam, Nijmegen, and 
Rotterdam, the Netherlands. 
Patients: Infants with complete unilateral cleft lip and palate 
(UCLP), no other malformations. 
Interventions: One group (IO+) wore passive maxillary plates during 
the first year of life, but the other group (IO-) did not. All other 
interventions were the same for both groups. 
Main Outcome Measures: Bottle feeding velocity (mL/min) at 
intake, 3, 6, 15, and 24 weeks (T0 to T24); weight-for-age, length-for-age, 
and weight-for-length using z scores; reference values from the 
Netherlands’ third nationwide survey on growth. 
Results: Feeding velocity increased with time from 2.9 to 13.2 
mL/min in the IO- group and from 2.6 to 13.8 mL/min in the IO+ group; 
no significant differences were found between groups. Weight-for-age, 
length-for-age, and weight-for-length (z scores) did not differ 
significantly between groups, but overall the infants with unilateral cleft 
lip and palate in both groups had significantly lower mean z scores for 
weight-for-age and height-for-age than the reference during the first 
14 months, and had lower mean values for weight-for-length after soft 
palate closure. 
Conclusion: Infant orthopedics with the aim of improving feeding 
and consequent nutritional status in infants with unilateral cleft lip and 
palate can be abandoned. 
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4.1 Introduction 
 
Infants with unilateral cleft lip and palate (UCLP) experience feeding 
difficulties due to the defect. Stabilization of the nipple is difficult, and 
infants with a UCLP are unable to generate or maintain negative pressure 
because air flows through the cleft, decompressing the negative pressure 
in the oral cavity.1,2 The only way they can extract milk from the nipple is 
by mechanical movements of the lips, tongue, and mandible that push the 
nipple against the cleft palate. This often results in prolonged feeding 
times or inadequate food intake, as well as increased risk for backflow 
through the nose (nasal regurgitation), choking, aspiration, and vomiting. 
Moreover, when feeding is unsuccessful, both parent and child become 
frustrated, so it is crucial that good feeding is acquired as soon as 
possible.3 
A general feeding solution in UCLP is to deliver milk directly into 
the mouth1 and to educate parents about feeding techniques, bottles, 
nipples, formula volume goals, and use of energy-dense additives.3 The 
most common instructions are to use a bigger cross-carved hole in the 
nipple, in combination with a squeeze bottle.4 It is also advised to hold 
the child in a more upright position.3 
Infant orthopedics (IO) is thought to have a favorable effect on 
feeding and to reduce feeding problems.3,5-7 Little sound evidence is 
available about the effects of IO on the feeding process. During IO, the 
cleft is covered artificially and the oral environment is normalized. This 
is thought to result in more effective feeding movements. However, Choi 
et al.2 found that, even in the presence of an orthopedic plate, negative 
pressure generation was not possible with UCLP. Turner et al.8 found an 
increase in flow-rate with bottle feeding combined with a feeding plate 
and lactation education. Although not to an adequate level, breastfeeding 
has been managed in some cases using a specially designed appliance.9 
Bokhout10 found that the presence of cariogenic lactobacilli were 
associated with the use of IO. This early colonization may imply a high 
risk for dental caries in the primary dentition and should also be taken 
into account when IO is used. 
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Growth of infants with cleft lip and palate is generally found to lag 
behind during infancy.11-17 However, authors who have reported on 
long(er) term results found catch-up gains in weight and/or height.11,13,17 
The factors most frequently mentioned regarding growth inhibition 
include feeding problems, recurrent upper airway and ear infections, and 
surgical interventions. Felix-Schollaart18 and Felix-Schollaart et al.19 
were the first to record the occurrence of feeding difficulties, as well as 
their influence on length and weight, among other variables. They 
reported a very low frequency of feeding difficulties, but that the 
explained variance (14%) of having feeding difficulties at a relatively late 
age (12 to 18 months) influenced weight and length negatively. Head 
circumference was not significantly influenced by feeding difficulties. 
Available information in the literature on the effects of IO on 
feeding and, subsequently, on weight and length seemed to be inadequate 
at the time of the preparation of this trial. Therefore, feeding variables 
and the anthropometric variables recommended by the World Health 
Organization,20 weight, and length were measured in Dutchcleft. In this 
prospective randomized clinical trial, the effects of IO in infants with a 
complete UCLP were evaluated. The trial started in 1993, in cooperation 
with the academic cleft palate centers of Nijmegen, Amsterdam, and 
Rotterdam, all in the Netherlands.21 The primary objective of the study 
was to assess general effects (feeding, infant growth, and parent’s 
satisfaction), orthodontic and surgical effects, speech, and cost-
effectiveness. The present paper reports on the effects of IO on bottle 
feeding during the first 24 weeks and on weight and length during the 
first year. The aims were to test whether IO increases the feeding velocity 
(mL/min), the amount of food intake per feeding, and the indices of 
weight-for-length (g/cm) and length-for-age (cm). 
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Table 1 Mean ages in weeks ± standard deviation (SD) at which questionnaires were 
filled in. N IO- and N IO+ are the number of returned questionnaires at a certain stage.  
 
Time N IO-* Age ± SD N IO+ Age ± SD 
T0 22  1.5 ± 0.9  21  1.2 ± 0.7 
T3 21  3.1 ± 0.4  16  3.1 ± 0.6 
T6 24  6.6 ± 0.7  20  6.3 ± 1.1 
T15 24  15.5 ± 1.0  17  15.3 ± 1.7 
Lip repair    18.2 ± 2.4   18.5 ± 1.9 
T24 21  25.4 ± 3.3  20  25.1 ± 2.7 
 
* IO- = no passive maxillary plate; IO+ = passive maxillary plate.  
 
 
Table 2 Background variables for both groups IO- and IO+; Some skewed variables 
are presented as percentiles. 
 
 IO- group* IO+ group 
Total eligible infants N = 25 N = 24 
Girl/boy 6/19 5/19 
Cleft left/right 16/9 15/9 
N by center 1/2/3 6/10/9 5/10/9 
Percentiles P10 P50 P90 P10 P50 P90 
Age at trial entrance (d)  1  6  13  0  3  7 
Birth weight (g)  2920  3600  4280  2660  3350  4020 
Alveolar cleft width at birth (mm)  8.6  12.4  16.4  9.5  12.5  14.4 
Age lip-repair (wk)  16.7  17.9  19.7  16.7  18.1  20.3 
Age soft-palate repair (wk)  43.0  52.4  55.6  50.7  53.6  62.6 
 
* IO- = no passive maxillary plate; IO+ = passive maxillary plate.  
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4.2 Materials and methods 
 
A detailed description of the experimental design, eligibility, treatment 
assignment, treatment protocol, and operators can be found in a previous 
publication.21 The most important issues are given below. 
 
4.2.1 Experimental design 
The experimental design was a prospective two-arm randomized 
controlled clinical trial in parallel. Three academic cleft palate centers in 
the Netherlands (Nijmegen, Amsterdam, and Rotterdam) participated. 
The study protocol was approved by the ethical committees of the three 
centers. The inclusion criteria were complete UCLP, infants born at term, 
both parents Caucasian and fluent in the Dutch language, and trial 
entrance within 2 weeks after birth. The exclusion criteria were other 
congenital malformations (except for syndactyly) and soft tissue bands. 
Parents of eligible infants were informed orally about the trial and invited 
to participate. When they agreed, a written informed consent was signed. 
Nonparticipating eligible infants were recorded, as well as the reason for 
nonparticipation. Between 3 and 6 months of age, all included children 
were confirmed by the geneticist of their own CLP team as being 
nonsyndromic. 
 
4.2.2 IO+ and IO- treatment 
The appliance used in the IO+ group was a passive plate consisting of two 
layers: one of soft acrylic that faced the oral and nasal tissues, and one of 
hard acrylic that supported the device. The plate covered the hard palate 
and the alveolar segments, and obturated the cleft (including the cleft of 
the soft palate.) The plate was inserted within a few days after intake and 
worn 24 hours a day. 
Initially, the plates were adjusted every 3 weeks in the clinic by 
grinding at the cleft margins to ensure proper approximation of the 
maxillary segments. A new plate was made whenever maxillary growth 
or inadequate retention indicated the necessity. After surgical lip closure, 
at 18 weeks of age, the plate was relieved in the lip region and reinserted 
the same day. From that moment on, maxillary dimensional changes 
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normally decreased, and checkup visits were planned for every 4 to 6 
weeks. The plate was maintained until surgical soft palate closure. 
The infants in the IO- group did not wear plates and only visited the 
clinic before and after lip surgery and soft palate closure in order to plan 
surgery and monitor the outcome of surgery. An extra checkup was done 
at the age of 6 weeks in order to monitor feeding and the well-being of 
parents and child. In both groups, lip surgery was performed according to 
the Millard technique (18 weeks of age); soft palate closure was 
performed according to a modified Von Langenbeck procedure (52 weeks 
of age). 
 
4.2.3 Feeding instructions 
Feeding instructions were given by the orthodontists in the three 
participating centers. In Nijmegen, this was also done by the team’s 
pediatric nurse. The most important issues of the instructions were the 
use of a squeeze bottle (Mead Johnson, Evansville, IN, or Haberman, 
Medela, Inc., McHenry, IL), in combination with a cross-carved hole in 
the nipple if necessary. It was also advised to hold the child in a more 
upright position, to allow regular burping, and to feed the child for no 
more than 30 minutes. 
 
Table 3 Percentages of infants who received breast milk; mean values and standard 
deviations (between brackets) of feeding background variables for both groups IO-* and 
IO+ (grey) at 5 ages; age at introduction of solids is given in percentiles for both groups. 
  
Time  T0‡ T3 T6 T15 T24 
Breast milk (%)† 24 20 18 10 2 
Breast milk (%)† 18 12 8 8 4 
Number of feedings per day   6.7 (0.5)  6.3 (0.5)  6.1 (0.8)  5.0 (0.4)  4.4 (0.6) 
Number of feedings per day   7.2 (1.2)  6.7 (0.8)  5.6 (0.9)  4.9 (0.6)  4.5 (0.9) 
Amount of milk per day (ml/d)   455 (149)  617 (142)  692 (102)  896 (85)  880 (146) 
Amount of milk per day (ml/d)   434 (183)  633 (108)  688 (95)  887 (102)  855 (96) 
Age at introduction of solids (wk)   P25 = 17 P50 = 20 P75 = 23  
Age at introduction of solids (wk)   P25 = 17 P50 = 19 P75 = 21.5  
 
* IO- = no passive maxillary plate; IO+ = passive maxillary plate.  
† Due to incidental missings = 8% for both groups in total.  
‡ T0 through T24  represent different ages as referred to in the text. 
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4.2.4 Data acquisition 
Because the evaluation of the feeding process was limited to bottle 
feeding, it was decided to evaluate feeding only during the period in 
which bottle feeding mainly occurred. Feeding log/questionnaires were 
handed out to the mothers at five different times, from intake until 24 
weeks of age. These ages were as soon as possible after birth (T0), at the 
age of 3 weeks (T3), at the age of 6 weeks (T6), before lip closure at 15 
weeks (T15), and after lip closure at 24 weeks (T24). At each point in 
time (T0 to T24), the log/questionnaire consisted of the same questions 
(open-ended and multiple-choice) on bottle feeding and was completed, 
from 15 weeks on, with seven questions on the introduction of weaning 
food. The log/questionnaires were appended with written instructions and 
blank spaces for remarks. Among the items questioned were food intake 
(length of feeding time, amount of milk consumed, and number of 
feedings), breast milk or formula, means of feeding, and age at which 
solids were introduced. The variables of feeding time and amount per 
feeding were used in order to calculate the outcome measure feeding 
velocity (mL/min) and total amount of milk per day (mL/d). 
Weight and length were measured by the national infant consultation 
centers according to the national protocol. Nude weight of the infants was 
measured to the nearest 5 g by means of a digital scale. Length was 
measured to the nearest 0.5 cm by using a horizontal measuring board 
with a sliding foot piece. The infants were measured monthly, according 
to the national protocol. 
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Table 4 Mean and standard deviations of the feeding variables (min, mL, or mL/min) 
for both groups IO-* and IO+ (grey) (Number (n), mean and standard deviation [SD]) 
 
 
* IO- = no passive maxillary plate; IO+ = passive maxillary plate. 
† T0 through T24 represent different ages as referred to in the text.  
 
4.2.5 Statistical analysis 
Means and standard deviations of the feeding variables (time per feeding, 
amount per feeding, and feeding velocity) were compared between both 
groups at five different ages. The differences were tested statistically by 
means of a t test, based on a probable error of p < .05. No tests were 
performed on the background variables, for they are used to describe the 
sample. The influence of IO, cleft width, and initial cleft width on 
feeding velocity (T0 to T24) was studied by multiple regression analysis. 
For evaluation of the anthropometric indices of weight-forage, 
length-for-age, and weight-for-length, z scores were chosen. The main 
reasons were allowing the pooling of the sexes in both groups, combining 
information at different ages (the Netherlands’ third nationwide survey 
on growth),22 and expecting the observed z scores to be normally 
distributed. Therefore, analytical procedures that assume normality, such 
as t tests and regression methods, may be used.23 Weight-for-length was 
chosen as the main outcome measure because it is very sensitive to 
weight change over a short time period.23 
At monthly intervals, mean values and standard deviations were 
calculated for the indices of weight-for-age, length-forage, and weight-
for-length. The differences between groups (IO+ and IO-) were tested 
statistically by means of a t test. The same indices’ values were also 
calculated at the following moments: before (M1) and after lip surgery 
 T0† T3 T6 T15 T24 
Time (n) mean (S.D.) (n) mean (S.D.) (n) mean (S.D.) (n) mean (S.D.) (n) mean (S.D.) 
Time per feeding (22)  26.8  (8.5) (21)  28.1  (9.0) (24)  22.3  (7.5) (24)   18.00  (5.3) (21)  16.6  (5.8) 
Time per feeding (20)  26.6  (8.4) (16)  25.9  (9.0) (20)  28.0  (11.3) (17)  21.5  (8.6) (20)  17.7  (6.3) 
Amount/feeding (22)  68.6  (23.0) (21)  98.3  (25.8) (23)  114.3  (20.5) (24)  177.1  (19.9) (21)  198.6  (15.7) 
Amount/feeding (20)  59.5  (26.8) (16)  96.3  (21.0) (20)  121.5  (21.3) (17)  180.9  (23.3) (19)  200.5  (23.9) 
Feeding velocity (22)  2.9  (1.6) (21)  4.0  (2.1) (23)  5.6  (2.3) (24)  10.8  (4.0) (21)  13.2  (4.2) 
Feeding velocity (19)  2.6  (1.6) (16)  4.2  (2.0) (20)  5.0  (2.3) (17)  9.8  (4.7) (19)  13.8  (8.1) 
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(M2), as well as before (M3) and after soft palate surgery (M4). 
Differences between groups were tested statistically by a t test. The 
differences between all infants with UCLP from the trial and the 
reference infants from the Roede and Van Wieringen study22 were 
analyzed by the one sample t test against zero on the z scores. 
 
Figure 1 Mean z scores (x100) of infants from both groups regarding length-for-age. 
The time range P10 to P90, during which lip closure was performed, is marked in between 
the curves. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Mean z scores (x100) of infants from both groups regarding weight-for-age. 
The time range P10 to P90, during which lip closure was performed, is marked in between 
the curves. 
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Figure 3 Mean z scores (x100) of infants from both groups regarding weight-for-
length. The time range P10 to P90, during which lip closure was performed, is marked in 
between the curves. 
 
 
 
 
 
 
 
 
 
 
 
 
4.3 Results 
 
From 1993 to 1996, 54 infants (41 boys, 13 girls) entered the trial, 27 in 
each group. A detailed description of the sample characteristics, the 
patient flow diagram through the study, and reasons for nonevaluation are 
published elsewhere.21 
Feeding records of 47 infants were available, although occasionally 
records were missing at different ages. The number of completed 
log/questionnaires and the mean age at each stage are presented in 
Table 1. Relevant background variables of the sample regarding this part 
of the study are presented in Table 2. In Table 3, background variables of 
the feeding process are presented. Three infants presented with a naso-
gastrointestinal tube at intake. For these infants, normal bottle feeding 
was accomplished shortly after, and the tubes were removed. 
As expected, the amount of food intake and the feeding velocity 
increased with time, and the time per feeding decreased with time in both 
treatment groups (Table 4). No significant differences were found 
between groups for these feeding variables. Infant orthopedics, cleft 
width, and initial cleft width together did not explain any variance (R2, 
4.0%) in feeding. 
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Regarding the growth data, only a few missing values were allowed 
in the longitudinal series of measurements. Forty infants fulfilled this 
condition (IO-, n=21, IO+, n=19). The growth curves for weight-for-age, 
length-for-age, and weight-for-length were constructed using the mean 
values calculated at monthly intervals (Figs. 1 through 3). Because the 
curves were constructed using the available data from the consultation 
centers, the curves start at the age of 2 months and end at the age of 14 
months. The results of the t tests revealed no significant differences for 
the above-mentioned indices. 
Weight, length, and weight-for-length (z scores) of both groups were 
compared at four predetermined moments (before [M1] and after lip 
closure [M2], and before [M3] and after soft palate closure [M4]). No 
significant differences were found between groups. However, the mean 
values (Table 5) of the infants with UCLP from the trial differed 
significantly from the reference infants from the Roede and Van 
Wieringen survey.22 Throughout the first year, they appeared to be 
significantly lighter and shorter. However, the mean z scores for weight-
for-length were significantly lower only after soft palate closure (M4), 
compared with the reference. 
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Table 5 Mean z scores and standard deviations for weight, length and weight-for-
length at 4 predetermined moments (M1, M2, M3 and M1) in wk (i.e. before and after lip 
closure, and before and after soft palate closure, respectively) for both groups: IO- † and 
IO+ (grey) and IO- and IO+ together: Number (n), mean, and standard deviations (SD).   
† IO- = no passive maxillary plate; IO+ = passive maxillary plate. 
*p≤ 0.05 and > .01,  **p≤ 0.01 or > 0.005. 
 
 
4.4 Discussion 
 
This study was part of the Dutchcleft randomized clinical trial assessing 
the effects of IO. It was our aim to evaluate the effects on feeding and 
consequent nutritional status in order to present scientific evidence for 
the claims for or against this type of treatment. In order to achieve this, 
the design used was a prospective two-arm randomized controlled trial in 
parallel with three academic cleft palate centers.21  
Infant orthopedics is used in more than 54% of the cleft palate 
centers in Europe, with different objectives for the use of an appliance.24 
It is the aim of IO to mold the alveolar segments either passively or 
actively, as well as to facilitate feeding. The indications for these 
appliances differ, as do designs, plate materials, and timing of use. 
Moreover, IO is used in combination with different surgical treatment 
 M1 M2 M3 M4 
 (n) mean (S.D.) (n) mean (S.D.) (n) mean (S.D.) (n) mean (S.D.) 
Age (21)  14.6  (3.2) (21)  22.0  (3.7) (21)  46.0  (4.5) (18)  60.8  (8.6) 
Age (19)  16.2  (6.3) (19)  24.5  (7.9) (18)  46.7  (7.8) (14)  58.3  (6.0) 
Age IO- and IO+ (40)  15.4  (4.9) (40)  23.1  (6.1) (39)  46.4  (6.2) (32)  59.7  (7.6) 
Length (21)  -0.51  (0.85) (21)  -0.40  (0.81) (21)  -0.41  (0.89) (18) -0.40  (0.80) 
Length (19)  -0.48  (0.98) (18)  -0.28  (1.07) (18)  -0.36  (0.90) (14)  -0.34  (0.78) 
Length IO- and IO+ (40)  -0.49 (0.90)** (39)  -0.34 (0.93)* (39)  -0.39 (0.88)* (32)  -0.37 (0.78)* 
Weight (21)  -0.57  (0.92) (21)  -0.49  (0.75) (21)  -0.48  (0.68) (18)  -0.83  (0.47) 
Weight (19)  -0.38  (0.91) (19)  -0.22  (0.99) (18)  -0.34  (1.13) (14)  -0.59  (1.05) 
Weight IO- and IO+ (40)  -0.48 (0.90)** (40)  -0.37 (0.87)* (39)  -0.41 (0.90)* (32)  -0.72 (0.77)**
Weight-for-length (21)  -0.05  (0.71) (21)  -0.15  (0.61) (21)  -0.12  (0.68) (18)  -0.36  (0.54) 
Weight-for-length (19)  -0.08  (0.57) (18)  -0.02  (0.63) (18)  -0.02  (0.94) (14)  -0.35  (0.93) 
Weight-for-length IO- and IO+ (40)  -0.01  (0.64) (39)  -0.07  (0.62) (39)  -0.07  (0.80) (32)  -0.36 (0.72)* 
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protocols, and the competence of the involved professionals is likely to 
vary. These aspects of IO emphasize that it is very important to make a 
clear distinction between the different appliances and to carefully 
describe all treatment variables in order to compare results from different 
studies. 
A quantitative method was used to study the effects of IO on feeding 
and anthropometric indices. Feeding time decreased during the study, 
from intake to 24 weeks. The amount of food and the feeding velocity 
increased during this period, as was expected. However, no differences 
were found between groups. During this period, the infants in the IO+ 
group returned to the clinic every 3 weeks. It might be possible that 
feeding was monitored better in the IO+ group than in the IO- group, 
influencing the outcome of the IO+ group in a positive way. Because 
there were no differences between the groups regarding the feeding 
variables, this possible confounder only strengthens the conclusion that 
IO has no measurable effect. This finding also supports the findings of 
Choi et al.2 that the presence of an orthopedic plate made no difference in 
the ability of infants with cleft lip and palate to generate the necessary 
negative pressure in the mouth. The claimed advantage that IO would 
result in more effective feeding, by covering the cleft, could not be 
substantiated. 
However, Turner et al.8 found an increase in flow-rate when bottle 
feeding was combined with a feeding plate and lactation education, in a 
small sample of eight mothers and infants. Although a significant positive 
effect of a feeding plate on feeding time and volume intake was reported, 
the number of children and the complex design of the study may have 
resulted in a chance positive outcome. Kogo et al.9 managed 
breastfeeding in some cases using a specially designed plate, although it 
was not to an adequate level. However, one can hardly speak of a positive 
effect of a feeding plate on the basis of the results of this study. 
The consequent nutritional statuses of the two groups in the current 
trial were evaluated by means of the adopted weight and length records 
from the Dutch consultation centers. Evaluation of the nutritional status 
is in accordance with the World Health Organization (WHO) working 
group,20 which recommends the use of anthropometric assessments in 
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order to evaluate response to treatment. Also, the anthropometric indices 
of length-for-age and weight-for-length discriminate between different 
physiological and biological processes, and the weight-for-length ratio is 
sensitive to small weight changes. Z scores were used as a scale allowing 
pooling of the sexes (maximizing sample sizes) and rendering statistical 
advantages because of normal distribution of the mean values.23 The z 
scores were calculated using the Netherlands’ third nationwide survey on 
growth22 as a reference. In the current study, weight-for-age, length-for-
age, and weight-for-length did not differ significantly between groups. 
However, the mean values for the infants with UCLP in the trial differed 
significantly from the reference. Not only were the infants with UCLP 
significantly lighter and smaller than the infants in the reference group, 
but the mean values for weight-for-length were also lower after soft 
palate closure. This last difference might be due to increased missing 
values at the end of the observation period, but could support the findings 
of Felix-Schollaart et al.19 that feeding difficulties experienced at a 
relatively late age (12 to 18 months) influence weight and length. The 
infants from the study of Felix-Schollaart et al.19 had IO during the first 
14 to 16 months, and suitability of the control data were checked using 
the same national growth study as the present study. 
This study is not the first to imply that infants with UCLP are lighter 
and smaller. Even though the literature is not consistent,11,13,16,18,19 the 
significance level and the magnitude of the differences show a relevant 
finding. Haschke and Van 't Hof25 reported that the educational level of 
the mother did not influence length or weight significantly and that mid-
parental height significantly influenced length and weight. The 
background variable of mid-parental height could have supported the 
relevance of the findings, but at the time this questionnaire was 
developed, this background variable was not yet included. Nevertheless, 
before the soft palate closure which marks the end of IO, the infants from 
this trial showed a normal weight-for-length ratio, which for the infants 
in question is the most important value of all. 
Based on the results of the present study, it can be concluded that the 
type of infant orthopedics used had no significant effects on feeding or 
consequent nutritional status, and that it can be discarded as a tool to 
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improve feeding and general somatic growth. In addition, we would 
recommend that users and researchers of other types of IO or feeding 
appliances evaluate, in addition to feeding advantages and general 
growth, all possible side-effects, such as restriction of maxillary growth. 
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Summary 
 
Objective: To study the effect of infant orthopedics on facial appearance. 
Design: Prospective two-arm randomized controlled trial in parallel 
with three participating academic cleft palate centers. Treatment 
allocation was concealed and performed by means of a computerized 
balanced allocation method. 
Setting: Cleft Palate Centers of Amsterdam, Nijmegen, and 
Rotterdam, the Netherlands. Patients: Infants with complete unilateral 
cleft lip and palate, no other malformations.  
Interventions: One group (IO+) wore passive maxillary plates during 
the first year, the other group (IO-) did not. 
Main Outcome Measure(s): Two metrical response modalities were 
used (i.e., visual analog scales and reference scores) to score facial 
appearance. Full face and cropped photographs were compared with 
reference photographs and were judged. The photographs were judged by 
45 judges, 24 laypeople, and 21 professionals. Transformation of the 
scores into z scores was applied to compare and to pool both response 
modalities. The validity of each individual judge was evaluated, as was 
the reliability of the scales. Differences between the treatment groups 
were evaluated by means of t tests.  
Results: Photographs were available of 41 subjects, 21 with and 20 
without infant orthopedics. No significant differences were found 
between groups. Mean z-score values for the full-face photographs were: 
group IO+ = 0.10 (SD = 0.73) and group IO- = -0.03 (SD = 0.48); for the 
cropped photographs were: group IO+ = 0.12 (SD = 0.71) and group IO- = 
-0.06 (SD = 0.55). 
Conclusions: Infant orthopedics have no effect on facial appearance. 
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5.1 Introduction 
 
The facial appearance of an infant born with a complete unilateral cleft 
lip and palate (UCLP) changes with time and is at each moment in time 
the result of intrinsic, functional, and extrinsic factors.1,2 At birth, the 
cleft lip usually is widely flared open and the maxillary segments are 
separated with a mean of approximately 12 mm at the level of the 
alveolar cleft.3 For the infant, the main problem is feeding. However, the 
initial facial impairment also will have its subsequent effects on parents, 
family, and later, social network. Fortunately the facial appearance of 
infants with cleft lip and palate (CLP) does not appear to affect the early 
mother-infant relationship adversely.4,5 Later, a normalized facial 
appearance in combination with good intelligibility6 generally is 
preferred by peers and is of great importance when socializing.7,8,9 
As the child grows older, several interventions (i.e., surgery, 
orthodontics, speech therapy) will have occurred to normalize function 
and facial appearance. In almost half of the European cleft palate teams, 
infant orthopedics (IO) is part of the treatment protocol.10 IO was 
introduced by McNeil.11,12 One of the arguments for the use of IO was to 
improve the presurgical alignment of the maxillary segments to facilitate 
lip/nose surgery. It was assumed by proponents of IO with a passive 
maxillary plate, as used in this study, that the cleft width would be 
reduced significantly and relevantly. The approximation of the alveolar 
segments and the cleft lip were assumed to result in reduced tension on 
the repaired lip and in a better treatment outcome.13,14 However, this 
claim has never been established.14 
The purpose of this study was to evaluate the effect of IO, using 
passive maxillary plates, on facial appearance at 18 months of age. The 
included infants were born with a complete UCLP. Two treatment groups 
were evaluated; one group received IO treatment during the first year of 
life, the other group did not. The material was collected as part of a 
clinical trial into the effects of IO, executed in cooperation with the 
academic cleft palate centers of Nijmegen, Amsterdam, and Rotterdam, in 
the Netherlands.3,15,16 The main objectives of the trial were to assess 
general effects (i.e., feeding, nutritional status, maxillary growth, facial 
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appearance, and parent’s satisfaction), orthodontic and surgical effects, 
speech, and cost-effectiveness. 
 
 
5.2 Materials and methods 
 
A detailed description of the experimental design, eligibility, treatment 
assignment, treatment protocol, and operators can be found in a previous 
publication.3 The most important issues are given below. 
 
5.2.1 Experimental design 
The experimental design was a prospective two-arm randomized 
controlled clinical trial in parallel. Three academic cleft palate centers in 
the Netherlands participated (Nijmegen, Amsterdam, and Rotterdam). 
The study protocol was approved by the three local ethical committees. 
The inclusion criteria were complete UCLP, infants born at term, both 
parents Caucasian and fluent in the Dutch language, and trial entrance 
within 2 weeks of birth. Exclusion criteria were other congenital 
malformations (except for syndactyly) and soft tissue bands. Parents of 
eligible infants were informed orally about the trial and were invited to 
participate. When they agreed, a written informed consent was signed. 
Subsequently, treatment allocation was concealed and was performed, for 
each individual center, by means of a computerized balancing allocation 
method.17 Two experimental groups were formed, one with IO and one 
without. Between 3 and 6 months of age, all included children were 
confirmed by the geneticist of their own CLP team as being 
nonsyndromic. For further details on the treatment protocols in both 
groups, the reader is referred to Prahl et al.3 
 
5.2.2 Data management 
Facial photographs were taken at the age of 18 months. By this time, lip 
and soft palate surgery had taken place and the short-term effect of IO 
could be evaluated. Judgment of facial appearance was performed by 
professionals and adult laypeople, also referred to as the judges. The 
adult laypeople (n = 24) were recruited mainly from the patient waiting 
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room in the dental school, Radboud University, Nijmegen. The 
professionals (n = 21) were recruited from cleft palate teams of the 
Medical Center of Amsterdam, the Medical Center of Leeuwarden, and 
Radboud University Nijmegen Medical Center, Nijmegen. 
The method used for rating facial appearance has been described by 
Peerlings et al.18 Two views were used to judge the facial appearance 
(i.e., a photograph showing the full face and a cropped version of the 
same photograph revealing a circle with the nose and mouth (Fig. 1). 
These experimental photographs were compared with the reference 
photograph and were judged subsequently. The reference photograph was 
chosen by two professionals from a selection of photographs representing 
the full range from poor to excellent aesthetic outcome. A good and clear 
photograph in the middle of the range was chosen as the reference 
photograph. For practical reasons, re-measurements were collected within 
one session using two different response modalities, reference scores and 
scores on a visual analog scale (VAS). Photographs were presented 
simultaneously with the reference photograph as color slides in a 
darkened room. The experimental slides were forwarded manually and 
the time lapse (20 seconds) was monitored with a stopwatch. All full-face 
photographs were scored first using the reference scores method, and 
second using VAS. The same procedure was followed for the cropped 
version of the photographs. To reduce memory effects, the photographs 
were presented in a random order each time and all clefts were presented 
as being left-sided. 
The score for the reference photograph was set arbitrarily at 100 and 
was given a fixed position on the VAS line. The judges were instructed to 
increase the score if facial appearance was considered better or more 
attractive than the reference. A similar instruction was given for the 
VAS: a right position from the reference position was recorded when the 
facial appearance was judged to be more attractive. A new form was used 
for each recording. Remarks about the quality of the photograph or other 
details from the picture that might have influenced the judgment also 
were recorded on the same form. Five photographs of patients outside the 
trial (cropped and full face) were used to familiarize the judges with the 
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material and both response modalities before the experimental 
assessments. 
 
 
Figure 1 Cropped photograph (i.e., the reference photograph used in this study). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Background variables for both groups IO- and IO+ (some skewed variables 
are presented as percentiles)* 
 
 IO- group IO+ group 
Total eligible infants n = 21 n = 20 
Girl/boy 4/17 3/17 
Cleft left/right 13/8 12/8 
n center 1/2/3† 6/8/7 5/7/8 
Percentiles P10 P50 P90 P10 P50 P90 
Age at trial entrance (d)  1  6  13  0  3  7 
Birth weight (g)  2954  3555  4301  2921  3258  4002 
Cleft width at birth (mm)  8.2  11.2  15.8  9.3  12.3  14.8 
Age lip-repair (wk)  16.7  18.0  20.2  16.8  18.2  20.5 
Age soft-palate repair (wk)  50.8  52.4  55.7  46.7  52.6  67.7 
 
* IO+ = with infant orthopedics; IO- = without infant orthopedics; cleft width at birth refers to the alveolar 
cleft width. 
† n = number at each of the thee centers: (1) Amsterdam, (2) Nijmegen, and (3) Rotterdam. 
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5.2.3 Statistical analysis 
The full-face and cropped photographs were judged using two response 
modalities (reference scores and VAS), rendering four series of scores 
(full-face reference scores, cropped reference scores, full-face VAS 
scores, and cropped VAS scores). The reproducibility of each individual 
judge was evaluated by means of Pearson’s correlation tests, testing the 
correlation between the mean values of the pooled reference scores, as 
well as the mean values of the pooled VAS scores of each individual 
judge with the respective mean value of all judges. The reliability of the 
final score (four subsequent series) was analyzed and was presented as 
Cronbach’s alpha. Reference scores and VAS scores may be seen as re-
measurements of each other. To compare and combine the scores of the 
response modalities (reference scores and VAS), transformation into z 
scores was applied. Mean z scores were calculated for the four series 
separately. The two response modalities were pooled together for the full-
face and cropped photographs (mean outcome measures). Differences 
between treatment groups regarding the pooled mean values for the full-
face and cropped photographs were evaluated by means of t tests. 
Measurement/remeasurement correlation and the correlation between 
full-face and cropped photographs also were expressed by means of 
Pearson’s correlation tests. Center and treatment effects, as well as their 
interaction, were tested by means of analysis of variance (ANOVA) on 
the pooled z scores for both types of photographs. Differences between 
the two response modalities were evaluated using a t test for paired 
samples with the original scores (numbers and millimeters). Gender 
differences were not analyzed, due to the young age of the participants. 
 
 
5.3 Results 
 
The number of all eligible randomized subjects was 49 infants (38 boys, 
11 girls). Detailed sample characteristics, the patient flow diagram, and 
reasons for non-evaluation for the whole trial were published elsewhere.3 
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Photographs were available of 41 children (mean age, 75 weeks; 
SD= 3). Relevant background variables are presented in Table 1. The 
gender disparity in the sample, as well as the disparity of left or right 
sidedness of the cleft, was consistent with the normal distribution in 
UCLP. 
No significant differences in VAS, reference scores, and total z 
scores were found between the ratings of laypeople and professionals (all 
p values > .70), and therefore judgments were pooled in all analyses. Six 
judges were excluded from one or more series, because their scores did 
not correlate well enough with the mean score (r < .50). The correlation 
of the remaining individual judges compared with the mean of the sample 
ranged from .52 to .83. 
The reliability of the four subsequent series was high (Cronbach’s 
alpha > .97). The measurement (VAS)/re-measurement (reference score) 
correlation was r = .97 for the full-face photographs and r = .96 for the 
cropped photographs. The correlation between the pooled full-face (VAS 
and reference score) and cropped photographs (VAS and reference score) 
was r = .91.  
 
 
Table 2 Mean outcomes of treatment groups IO- and IO+. Reference z-scores and 
visual analogue scale z-scores pooled together for full face and cropped photographs* 
 
 IO- IO+  
Photograph (n) mean (S.D.) (n) mean (S.D.) P value 
Full face (21) -0.03 (0.48) (20) 0.10 (0.74) P > .51 
Cropped (21) -1.06 (0.55) (20) 0.12 (0.71) P > .35 
 
* IO+= with infant orthopedics; IO- without infant orthopedics. 
 
Table 2 shows the results from the t tests analyzing the differences 
between the two treatment groups. No significant differences were found 
between mean values of the treatment groups (full face and cropped, p 
values > .35). The maximum and minimum z-score values were -1.23 to 
1.41 for the full-face photographs and -1.32 to 1.57 for the cropped 
photographs. Using the pooled z scores for each type of photographs as 
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the dependent variable, the results of the ANOVA, testing center, and 
treatment effects (IO), as well as their interaction, showed that neither a 
center or treatment effect could be detected (center and treatment effect, 
p values > .05). The results from the comparison of the two response 
modalities showed that the reference scores were more discriminative 
than was the VAS score. The evaluation of the two response modalities 
showed that the full-face photographs were judged significantly more 
attractive (p < .001) than were the cropped photographs when using the 
reference scores, but only slightly significant when using the VAS 
(p = .050; Table 3).  
 
Table 3  Mean outcomes of full face photographs and cropped photographs. 
Reference scores and visual analogue scale scores before transformation into z-scores.* 
 
 Full face photograph Cropped photograph   
Response modality (n) mean (S.D.) (n) mean (S.D.)  P value 
Reference scores (41) 80 (16) (41) 75 (19)  P < .001 
VAS (mm) (41) 55 (14) (41) 53 (13)  P = 0.05 
 
* Differences were evaluated by means of t-tests for paired samples.  
 
To illustrate the otherwise abstract z score to the reader, the results of all 
participants were pooled together and a 5-point scale was subsequently 
constructed for the cropped photographs. The range between each point 
on the scale was set at the 10th, 30th, 50th, 70th, and 90th percentiles of 
the total range between the minimum (poor) and maximum (good 
aesthetic outcome) value. Participants matching the calculated scores 
were selected for the scale (Fig. 2). 
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Figure 2 A 5-point scale was constructed using the cropped photographs from the 
trial. The range between each point on the scale was set at the 10th, 30th, 50th, 70th, and 
90th percentiles of the total range between the minimum (poor) and maximum (good 
asthetic outcome) value. A: Participants matching the 10th percentile. B: Participant 
matching the 30th percentile. C: Participant matching the 50th percentile. D: Participant 
matching the 70the percentile. E: Participant matching the 90th percentile.  
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5.4 Discussion 
 
In the cleft lip and palate literature, facial appearance usually has been 
judged from photographs.19 High correlations were reported between 
judgments in vivo and from photographs20 and adequate correlations 
when comparing judgments from video recordings.21 Tobiasen et al.22 
reported that correlations between full frontal and cropped frontal ratings 
were high and that cropped photographs revealing the nose and mouth 
may suffice. Cropping also helps to maintain the anonymity of the 
patients involved. 
Most often, 5-, 7-, or 9-point bipolar (attractive/non-attractive) 
scales have been used, followed by metrical scales (i.e., VAS or number 
scores), paired comparison technique and ranking.8,22-28 In the present 
study, two response modalities were used according to Peerlings et al.18 
The advantage was that the method had been proven reliable and re-
measurements were collected during the same session. The reliability in 
Peerling and colleagues’ study ranged from Cronbach’s alpha .84 to .94. 
In the present study, the reliability was even higher (Cronbach’s alpha > 
.96). Asher-McDade et al.23 found a reliability of .65 when scoring 
nasiolabial appearance using VAS and a reliability of .60 when using a 
5-point bipolar scale. 
Reliable judgments of facial aesthetics can be made by individuals 
who may vary widely in age, socioeconomic status, and gender.9 In the 
present study, no significant differences were found between the ratings 
of laypeople and professionals. The range for the correlation of the 
individual judge compared with the mean was .40 to .87 in the study by 
Peerlings et al.18 In the present study, the correlation ranged from .52 to 
.83.  
An interesting finding from this study was the fact that reference 
scores appeared more discriminative than VAS. Also, full-face 
photographs were judged more attractive than were the cropped versions. 
A possible explanation for the latter may be that other characteristics of 
the face and variation of response to babyishness and cuteness29 
determine the judgment. This is in agreement with the findings of 
Tobiasen8 and Asher-McDade et al.24 Although the primary purpose of 
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the trial was to investigate the differences in facial attractiveness, a scale 
was constructed using the cropped photographs from the trial to illustrate 
the otherwise abstract z score (Fig. 2). This scale could be used in future 
studies on facial attractiveness in children with UCLP. 
Because many studies on the effect of IO have a retrospective design 
and, quite often, a small sample size; lack a control group of UCLP 
children without IO; do not take confounding variables into account; or 
measure only at a certain age, the effectiveness of IO still remains 
uncertain.14,30-33 Therefore, a state-of-the-art randomized clinical trial 
design was chosen to investigate the effect of IO in children with 
complete UCLP. The findings of the part of the Dutchcleft study 
presented here show that IO has no effect on early aesthetic outcome. It 
remains to be investigated further whether differences between groups 
develop at a later age. The results are in agreement with the other 
findings of this trial to date. Except for a small but significant 
improvement in speech development, no positive or negative influence of 
IO was found in the Dutchcleft study.3,15,16,34-36 Therefore, from the 
orthodontic and surgical point of view, there is no need to perform IO in 
children with UCLP. 
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Summary 
 
Objective: To study the effect of infant orthopedics (IO) on the 
satisfaction in motherhood. 
Design: Prospective two-arm randomized controlled trial in parallel 
with three participating academic Cleft Palate Centers. Treatment 
allocation was concealed and performed by means of a computerized 
balanced allocation method. 
Setting: Cleft Palate Centers of Amsterdam, Nijmegen and 
Rotterdam, the Netherlands 
Patients: Two groups of infants with complete UCLP (N=54),no 
other malformations. 
Interventions: Group IO
+
 (N=27) wore passive maxillary plates 
during the first year life, group IO
-
 (N=27) did not. 
Main Outcome Measure(s): Mean satisfaction scores were obtained from 
completed questionnaires at 6, 24 and 58 weeks of age. A 4-point scale 
was used (1=very satisfactory to 4=very unsatisfactory). 
Results: The range of the mean scores for the individual items on the 
questionnaires for both groups ranged between 1.1 and 2.4. No 
differences were found between groups. Mothers appear to be satisfied in 
motherhood, least satisfied with the available time for themselves and 
very satisfied with hugging and walking their baby. No differences were 
found between groups 
Conclusions: Results from the present study show that IO, with a 
passive plate during the first year of life, in children with CUCLP has no 
influence on their mothers satisfaction in motherhood. 
Keywords: cleft palate; infant orthopedics; randomized controlled 
trial; treatment outcome; multi-center study; personal satisfaction. 
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6.1 Introduction 
 
In children born with cleft lip and palate (CLP) the quality of life (QoL) 
is already influenced at birth, by the impact of the conditions on the 
infant, mother and family. Not only does the birth of a child with CLP 
raise controversial emotions in the parents especially in the mother.
1
 But 
the parents also have to adjust to the loss of the anticipated perfect child.
2
 
The contradictory feelings, clashing interests between the parents and 
others and the conflicting ideas about what is best for the child illustrate 
the complexity of the relationship between parents and child.
1
 On top of 
this the infant is bound to have reconstructive surgery of the cleft lip/nose 
and soft palate in the first year of life, and in half of the European CLP 
teams, infants also receive infant orthopedics (IO).
3
 This latter type of 
early treatment with palatal appliances was introduced about 50 years ago 
in order to narrow the cleft presurgically. Since its introduction different 
type of appliances with different objectives have been introduced of 
which many are still in use.
4,5
 Opponents claim that that there is 
insufficient scientific data to support the use of IO, that IO is expensive 
and not cost effective. Claimed advantages of IO in the literature are 
amongst others: facilitation of lip surgery due to the narrowed cleft, a 
more normalized tongue tip function; less feeding problems; restoring the 
symmetry of the maxilla and nose; straightening of the nasal septum; 
better speech development; minimization of the severity of skeletal and 
dental deformities, thus less orthodontics and surgery later on and thus 
cost-effective; psychological support for parents and psychological 
advantages for the child due to better child-parent interaction.
5
 A positive 
treatment experience with IO during the early phases of care could affect 
the mother-child relationship positively. Psychological advantages and 
support for the mother and child due to a more frequent child-parent-team 
interaction as well as being able to participate actively in treatment as a 
parent due to IO have been claimed and discussed.
6-9
 The claimed 
psychological advantage of IO would certainly be welcome since parents 
of infants with CLP are reported to have higher levels of parental stress 
in infancy and toddler hood.
10
 In addition Speltz et al.
11
 found that 
mothers of CLP reported less favorable social support than mothers of 
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children with less visible malformations. Perceived family support was 
according to Bradbury
2
 the only significant variable related to parental 
adjustment. On the other hand most children with CLP emerge from the 
first 2 years of life with secure maternal attachment.
12
  
So far all evidence on “psychological effects of IO” has emerged 
from expert opinion but was never evaluated scientifically. Therefore, in 
this study, the satisfaction in motherhood in relation to the care of their 
child with or without IO was studied in a randomized controlled trial 
design.  
 
 
6.2 Materials and methods 
 
A detailed description of the experimental design, eligibility, treatment 
assignment, treatment protocol and operators can be found in a previous 
publication.
13
 The most important issues and specific information for this 
part of the study are given below. 
  
6.2.1 Experimental design 
The experimental design was a prospective two-arm randomized 
controlled trial in parallel. Three Dutch academic cleft palate centers 
(Nijmegen, Amsterdam and Rotterdam) participated after the study 
protocol was approved by the three local ethical committees. The 
inclusion criteria were: complete unilateral CLP (UCLP), infants born at 
term, both parents Caucasian and fluent in the Dutch language and trial 
entrance within 2 weeks after birth. The choice for Caucasian infants was 
based on two important issues: bias due to ethnic differences regarding 
growth, speech and language development, as well as the impossibility to 
create additional treatment groups with adequate power due to the low 
prevalence of infants with UCLP from other ethnic backgrounds in the 
Netherlands. Exclusion criteria were other congenital malformations 
(except for syndactily), and soft tissue bands. Parents of eligible infants 
were informed orally about the trial and invited to participate. When the 
parents agreed to participate a written informed consent was signed. 
Subsequently treatment allocation was concealed and performed for each 
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individual centre, by means of a computerized balancing allocation 
method.
14
 Two experimental groups were formed, one with infant 
orthopedics and one without. Between 3 and 6 months of age all included 
children were checked by the geneticist of their own CLP team as being 
non-syndromic. In total 54 infants with CUCLP were included in the 
trial. In previous publications from this trial,
13,15-17
 however, 5 infants 
were excluded from further evaluation because of the presence of soft 
tissue bands and in one case the presence of a contra-lateral sub-mucosal 
cleft lip was diagnosed. In this part of the clinical trial satisfaction was 
assumed not to be influenced by the presence of these features. As result 
of this assumption completed questionnaires from all 54 infants (27 in 
each treatment group) were included for evaluation. 
For further details on the treatment protocols in both groups the 
reader is referred to Prahl et al.
13
  
 
6.2.2 Data management 
  
In order to measure the satisfaction in motherhood a satisfaction 
questionnaire was used. The questions were derived from the experiences 
from a longitudinal study into mother-child attachment in CLP.
18,19
 The 
questionnaire was subdivided into 4 domains and contained 42 questions 
(items): 
 Domain 1: Interaction and caretaking of the baby (12 items), these 
questions concern the pleasure experienced during interaction when 
cuddling, consoling, playing walking, visiting, caretaking when 
feeding, bathing, dressing, changing, including interaction when 
baby was crying and getting the baby out of bed. 
 Domain 2: Comings and goings of the baby (10 items), these 
questions concern feelings of the mother towards the comings and 
goings of the baby i.e.: sleeping, feeding and their timing, digestion, 
conduct during the day, reaction of the baby during interaction and 
when left on/to-play-by its own. 
 Domain 3: Motherhood and life outside (10 items), the questions 
concern the feelings of the mother towards motherhood (specifically 
and quality of life), life outside of motherhood i.e.: relationship with 
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partner, own spirit, family spirit and housekeeping; sufficient time 
for other occupations or pursuits than the baby within the house or 
outside the house; time for my-self, and time for friends and 
relatives. 
 Domain 4: Support (10 items), the questions concern the support 
from partner, relatives, acquaintances and friends and others for 
mental support, caretaking, housekeeping; as well as support, 
information and advise from the cleft team, general physician, other 
medical institutions; adequate contact with other parents and parents 
of children with clefts. 
  
For the response a four item scale was used: 
1. very satisfactory, very happy, a lot of fun, more than adequate  
2. satisfactory, happy, often fun, adequate 
3. unsatisfactory, unhappy, not so much fun, inadequate 
4. very unsatisfactory, very unhappy, no fun, very inadequate. 
 
It was decided to evaluate satisfaction in the beginning of IO treatment, 
halfway IO treatment and after IO treatment had ended. Questionnaires 
(including written instructions on the first page) were handed out by the 
orthodontists of the cleft teams, during a routine check up planned at the 
ages of T1: 6, T2: 24 and T3=: 58 weeks. The mothers were asked to 
complete and return the questionnaire around the previously mentioned 
ages. 
  
6.2.3 Statistical analysis 
The data from the returned questionnaires were evaluated and analyzed 
statistically. Factor-analysis was performed within the domains. The 
reliability of the questionnaire was determined with Cronbach’s alpha as 
well as for each domain separately. Differences between the mean values 
of the two treatment groups, IO
+
 and IO
-
, of each domain as well as for 
the questionnaire were tested with t-tests at T1, T2 and T3. In order to 
check for center effects and for interactions between center and IO, a 
two-way analysis of variance was performed for the questionnaire at T1, 
T2 and T3 with IO and center as the dependent variables. Finally the 
Chapter 6 
 112 
results from both treatment groups were pooled in order to identify the 
factors containing the items with the highest and lowest mean scores.  
 
 
6.3 Results 
 
Questionnaires were available from 49 mothers. The number of the 
included questionnaires fluctuated due to questionnaires not being 
returned or completed around the target age. The age range for the 
completed questionnaires was T1: 4-9 wk, T2: 22-28 wk and T3: 55-66 
wk. The reliability (Crohnbachs Alpha) of the 4 domains ranged between 
α=0.66–0.85 and the reliability of the total questionnaire (all 4 domains 
together) was α=0.88. The reliability of the domains could not be 
improved by leaving out any items. The results for all 4 domains and for 
the questionnaire as a whole are presented in table 1-5. No significant 
differences (t-tests) were found between the groups IO
+
 and IO
-
 at T1, T2 
and T3 (Table 1 to 5).  
 
Table 1 Domain 1 (interaction and caretaking of the baby), mean satisfaction scores 
for both groups IO
-
 and IO
+
 (grey), number of participants (N), standard deviation (SD) 
and 95% confidence interval (95% CI) at T1, T2 and T3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IO-: treatment group without IO, IO+: treatment group with IO, T1: 6 wk of age, T2: 24 wk of age, T3: 
58 wk of age. 
Age IO N Mean SD 95% CI P 
       
T1 
IO- 26 1.30 0.25 
-0.27, 0.28 0.930 
IO+ 23 1.42 0.26 
       
T2 
IO- 24 1.30 0.21 
-0.18, 0.10 0.588 
IO+ 23 1.33 0.25 
       
T3 
IO- 19 1.42 0.27 
-0.23, 0.16 0.387 
IO+ 18 1.46 0.31 
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Table 2 Domain 2 (comings and goings of the baby), mean satisfaction scores for 
both groups IO
-
 and IO
+
 (grey), number of participants (N), standard deviation (SD) and 
95% confidence interval (95% CI) at T1, T2 and T3. 
 
 
 
 
 
 
 
 
 
 
 
 
IO-: treatment group without IO, IO+: treatment group with IO, T1: 6 wk of age, T2: 24 wk of age, T3: 
58 wk of age. 
 
 
Table 3  Domain 3 (motherhood and life outside), mean satisfaction scores for both 
groups IO
-
 and IO
+
 (grey), number of participants (N), standard deviation (SD), 95% 
confidence interval (95% CI) and p-value (P). 
 
 
 
 
 
 
 
 
 
 
 
 
IO-: treatment group without IO, IO+: treatment group with IO, T1: 6 wk of age, T2: 24 wk of age, T3: 
58 wk of age. 
   
Age IO N Mean SD 95% CI P 
       
T1 
IO- 26 1.45 0.31 
-0.38, 0.07 0.142 
IO+ 22 1.61 0.45 
       
T2 
IO- 24 1.29 0.23 
-0.20, 0.10 0.678 
IO+ 23 1.33 0.27 
       
T3 
IO- 19 1.27 0.22 
-0.29, 0.04 0.521 
IO+ 18 1.40 0.28 
Age IO N Mean SD 95% CI P 
       
T1 
IO- 26 1.79 0.37 
-0.30, 0.16 0.507 
IO+ 22 1.85 0.42 
       
T2 
IO- 24 1.68 0.38 
-0.26, 0.23 0.512 
IO+ 23 1.69 0.44 
       
T3 
IO- 19 1.56 0.34 
-0.41, 0.08 0.491 
IO+ 18 1.72 0.40 
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Table 4 Domain 4 (support), mean satisfaction scores for both groups IO
-
 and IO
+
 
(grey), number of participants (N), standard deviation (SD) and 95% confidence interval 
(95% CI) at T1, T2 and T3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IO-: treatment group without IO, IO+: treatment group with IO, T1: 6 wk of age, T2: 24 wk of age, T3: 
58 wk of age. 
 
 
Table 5  Mean satisfaction scores of the questionnaire as a whole (4 domains) for 
both groups IO
-
 and IO
+
 (grey), number of participants (N), standard deviation (SD) and 
95% confidence interval (95% CI) at T1, T2 and T3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
IO-: treatment group without IO, IO+: treatment group with IO, T1: 6 wk of age, T2: 24 wk of age, T3: 
58 wk of age. 
Age IO N Mean SD 95% CI P 
       
T1 
IO- 26 1.48 0.28 
-0.31, 0.04 0.653 
IO+ 22 1.61 0.31 
       
T2 
IO- 24 1.56 0.34 
-0.21, 0.19 0.893 
IO+ 23 1.57 0.33 
       
T3 
IO- 19 1.48 0.25 
-0.26, 0.14 0.117 
IO+ 18 1.54 0.35 
Age IO N Mean SD 95% CI P 
       
T1 
IO- 26 1.50 0.22 
-0.25, 0.05 0.199 
IO+ 23 1.60 0.29 
       
T2 
IO- 24 1.45 0.19 
-0.15, 0.10 0.299 
IO+ 23 1.48 0.24 
       
T3 
IO- 19 1.43 0.20 
-0.24, 0.05 0.352 
IO+ 18 1.53 0.24 
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Mothers from both groups appeared to be satisfied to the same degree and 
the mean level of satisfaction was positioned between very satisfactory 
and satisfactory in both groups. 
Factor-analysis within the domains resulted in 10 factors (Table 6) 
and showed high correlation between the items within the resulting 10 
factors. The contents of the items within each factor were explicable and 
logical. All items were included within the 10 factors and were evenly 
distributed amongst the factors. Since the reliability of the domains could 
not be improved by leaving out one or more of the items no attempt was 
made to further analyze the factors. 
 
Table 6 Results of  the factor analysis within the 4 domains, the factors are presented 
within the corresponding domain 
 
Domain 1 
Factor 1 Satisfaction with taking care of the baby (4 items) 
Factor 2 Fulfillment experienced when interacting with the baby like hugging and consoling 
(4 items) 
Factor 3 Fulfillment experienced when interacting with the baby like playing, walking and 
visiting (4 items) 
Domain 2 
Factor 4 Satisfaction with functioning of the baby like sleeping eating (6 items)  
Factor 5 Mother’s judgment of the baby’s the reaction towards comforting hugging playing 
(4 items) 
Domain 3 
Factor 6 Satisfaction in motherhood in general, relationship, family spirit and overall 
satisfaction since the birth of baby (6 items) 
Factor 7 Satisfaction in life outside of motherhood, sufficient time for other occupations or 
pursuits (4 items) 
Domain 4 
Factor 8 Satisfaction with support of partner (3 items) 
Factor 9 Satisfaction with support of professionals and other parents (4 items)  
Factor 10 Satisfactions with support from friends and family (3 items) 
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The pooled results from both treatment groups IO
+
 and IO
-
 showed 
highest mean satisfaction scores for the item from factor 2 (domain 1): 
“do you like to hug your baby” (mean score=1.06, SD=0.32), from factor 
3 (domain 1): “do you like to take your baby for a walk” (mean 
score=1.11, SD=0.32) and for the item from factor 5 (domain 2): “do you 
feel satisfied with the baby’s reaction when hugging” (mean score=1.14, 
SD=0.37). The lowest mean satisfaction scores were found for the item 
from factor 7 (domain 3): “do you feel you have sufficient time  for 
yourself” (mean score=2.26, SD=0.71) and for the item from factor 9 
(domain 4): “do you feel you have sufficient contact with other parents of 
children with clefts” (mean score=2.24, SD=0.81).  
 
 
6.4 Discussion 
 
It is the challenge and aim of the cleft palate teams to render optimal care 
and to guard or improve the quality of life of their patients. Because 
resources and professional help are limited, treatment has to be cost 
effective or in severe rare cases efficacious and worth the possible 
(worst) side-effects. The right attitude of the professionals to care, good 
quality management of the CLP team and its organization is the only way 
to establish, assure and improve the contents of care delivered by the 
team. Assessment of patient satisfaction and the quality of life is an 
essential part of treatment outcome and quality management and should 
therefore be included in the outcome measures. 
There is information available about the psychological well-being of 
CLP patients and their parents,
10,20-22
 but the interaction with treatment is 
a field that needs further exploration. It was concluded in the report, on 
the WHO meetings on international collaborative research on craniofacial 
anomalies,
23
 that more and better clinical research is needed and equally 
important consensus has to be reached about outcome measures 
especially for psychological variables and quality of life. This part of the 
clinical trial (Dutchcleft) into the effects of IO contributes to the 
knowledge of early psychosocial factors regarding the interaction of 
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treatment and satisfaction in motherhood. Although one would like to 
measure the quality of life of the patient, it is not measurable early in life. 
Alternatively the satisfaction in motherhood was measured because the 
bigger personal investment in care in case of IO and the increased 
psychological support by the team may introduce differences in the 
appreciation of different aspects of motherhood regarding the experience 
with IO and the perceived support. It was decided to evaluate satisfaction 
in motherhood since the mother is usually the primary caretaker in the 
Dutch society at least during the first year of life. The questionnaire in 
this study was administered during the treatment period with IO and 
several weeks after its dismissal (6-58 wk). The reliability was good and 
the factor analysis included all items and was logical and explicable. 
Differences in the appreciation of motherhood between mothers with or 
without the experience with IO in time, and between centers ranged 
between 0.03 to 0.16 and were never statistically significant. The power 
of the trial was sufficient to demonstrate significant differences when 
larger than 0.2 to 0.25. If differences were found between groups larger 
than 0.2 these would have been significant. This was not the case. 
Therefore it is not plausible that differences in satisfaction in motherhood 
will develop in the long run as a result of IO within a CLP population. 
For this reason no future measurements are intended during the follow up 
of this clinical trial. 
 Recently but unfortunately after the onset of this clinical trial new 
evidence regarding the negative effect of parental stress was reported by 
Pope et al.
10
 Pope et al., reported higher levels of parental stress in 
infancy and toddler hood for a CLP population. When consistent over 
time this may lead to higher levels of adjustment problems when children 
reach toddler hood. It is however unclear to what extend satisfaction in 
motherhood is associated with this emotional state, and thus it remains 
unclear if IO has any (lasting) influence on parental stress, for the better 
or for the worse. It has however been shown from the present study that 
there was no difference between groups in the perceived support from 
partner, family or from professionals which according to Bradbury
2
 is an 
important variable related to parental adjustment. 
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All in all the mothers responded positively to the questions 
indicating “satisfaction in motherhood” during the first year of life. 
Mothers were most satisfied with hugging and walking their baby and 
less satisfied with the time for other occupations or pursuits, the 
perceived support and the information and the advice from the cleft team, 
the general physician and other medical institutions. This is in 
accordance with the findings of Speltz et al.,
11
 who found that mothers of 
children with CLP reported less favorable social support than mothers of 
children with less visible anomalies. Last but not least mothers 
experienced inadequate contact with other parents especially parents with 
children with clefts. Professionals and parent support associations should 
use these findings to improve the quality of care.  
 
 
6.5 Conclusions 
 
Results from the present study show that IO, with a passive plate during 
the first year of life, in children with a CUCLP has no influence on their 
mothers satisfaction in motherhood. 
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7.1 Introduction 
 
This thesis is part of an ongoing randomized clinical trial (RCT) on the 
effects of infant orthopedics (IO) in UCLP of which the results regarding 
maxillary growth and development, feeding and nutritional status, 
esthetics, and satisfaction in motherhood, from birth until 1.5 yr of age 
are presented and discussed. The continuous discussion between 
proponents en opponents of IO, the lack of scientific evidence for the use 
of IO as well as the growing notion by the orthodontists of the 
participating CLP-teams that the contribution of IO might be irrelevant 
and therefore not costeffective marked the onset of this RCT. The 
outcome was measured comprehensively and the use of reproducible and 
valid outcome measures was strived for. 
 
 
7.2 Strengths and weaknesses of the current study 
 
7.2.1 Study design and trial organization 
A randomized two-arm clinical trial class IV design was chosen for this 
study because it is a fair test of treatment that will obtain reliable 
information about treatment effects by reducing play of chance and 
misleading influence of biases. Comparisons of the two arms, IO treated 
and non-IO treated individuals, was considered essential in order to 
address genuine uncertainties about treatment effects. In addition, the 
intention to treat principle was applied implying that the patient remains 
in the assigned treatment group for evaluation even if the patient is not 
compliant. This was based on the decision to measure the effects of 
common practice as is done in a RCT class IV and not the absolute 
efficacy which usually is not equal to the outcome of normal practice.
1
  
Before the intake of infants started the RCT protocol was approved 
by the trial organization, including all participating professionals, and as 
obligatory the ethical committees of the participating CLP centers. The 
RCT organization consisted of a trial board, a monitoring committee and 
a coordinating center. Fortunately the trial board never had to meet for 
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any trial violations or deviations and the protocol was adhered to by the 
professionals. 
 
7.2.2 Statistical aspects 
Regarding the statistical evaluation of the data, compensations were not 
applied for the possible confounders: socio-economic status, parity of the 
child, mid-parent-height, and dwelling place. For the nutritional status z-
score transformation was applied in order to compensate for the possible 
confounder, gender. The other confounders mentioned above, except for 
mid-parent-height, were not considered to be of major influence during 
infancy. 
Sample size calculation was based on the detectable IO effect (3 
degrees) on the cephalometric variable angle SNA for 4 yr olds. This 
variable represents the sagital midfacial development, which is 
considered to be one of the most important areas influenced by CLP 
therapy. The minimum number of participants was calculated at 23 per 
group. Even though 3 CLP centers participated the intake period took 3 
years. No additional sample size calculations were done for early speech 
and language development in CLP because of lack of information in 
order to estimate the standard deviation of the variables. However, 
research by Koopmans van Beinum et al.
2
 showed that a small sample 
size was sufficient to detect at least a number of differences in early CLP 
language and speech development. It was assumed therefore that the 
sample sizes for assessing orthodontic differences would ensure 
sufficient power to test differences in the field of speech and language. 
Limitations of this trial were, as could be expected, that the relevance of 
the outcome is limited to the target population, the long duration of the 
intake period (3 yr) and the lack of information regarding patient 
satisfaction and quality of life with treatment. 
 
7.2.3 Standardization, treatment, patients 
In order to standardize treatment, all participating specialists joined 
consensus meetings. Consensus was reached on timing and type of the 
surgical interventions and the surgeons standardized their surgical 
techniques. The participating surgeons had 7 to 30 yr experience in CLP 
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surgery and the participating orthodontists had 6 to 28 yr experience with 
IO prior to the RCT. The mean “annual” volume of children with clefts of 
each centre during the intake period (1993-1996) was: Nijmegen 56 
infants, Amsterdam 25 infants and Rotterdam 46 infants. Although it was 
aimed at to involve only three to five surgeons, one or two in each centre, 
due to retirement and other circumstantial reasons the total number of 
surgeons turned out to be 7 (lip surgery), of whom 5 surgeons were 
involved in soft-palate surgery. However, the majority (88%) of the 
operations were performed by the CLP team‟s main surgeons.  
In the present study the inclusion criteria were: complete UCLP, infants 
born at term, both parents Caucasian and fluent in Dutch, and trial 
entrance preferably within 2 wk after birth. The exclusion criteria were: 
other congenital malformations (except for syndactily), and soft tissue 
bands. The choice for Caucasian infants was based on two important 
issues: bias due to ethnic differences regarding growth, speech and 
language development, as well as the impossibility to create additional 
treatment groups with adequate power due to the low prevalence of 
infants with UCLP from other ethnic backgrounds in the Netherlands. 
The remaining inclusion and exclusion criteria were installed in order 
avoid their misleading influence of bias. In total 54 infants (41 boys, 13 
girls) entered the trial, 27 in each treatment group. These patients 
comprised all eligible patients during the intake period, except for one 
infant, whose parents refused participation because of the burden of 
compliance. It was decided that five patients were excluded from further 
evaluation: 4 patients were diagnosed with the presence of soft tissue 
bands and in one case a submucosal bilateral cleft lip was present. It has 
been demonstrated by Semb and Shaw
3
 that the presence of soft tissue 
bands may lead to a slightly more favorable maxillo-mandibular 
relationship and may therefore introduce bias.  
Regarding IO treatment, 2 of the 27 IO patients hardly used the 
plates and in one case the final plate remained in situ until the age of 1.5 
yr, by the parent‟s mistake. According to the intention to treat policy all 
patients remained in their assigned treatment group. 
In terms of treatment effect, the sole attribute of IO is only 
expressed in the early period prior to lip surgery, IO was dismissed 
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immediately after soft palate surgery. To avoid interference with the 
outcome of IO, type and timing of the surgery were kept the same for 
both groups. 
During soft palate closure additional lip corrections were performed 
in 13 children (IO(-): n=5; and IO(+): n=8). Two children in the IO(+) 
group had to be reoperated due to dehiscence of the soft palate. The claim 
by proponents of IO that it will reduce the number of revisions can 
normally not be substantiated at this early age. However, it is remarkable 
that most revisions, performed simultaneously with soft palate closure, 
were done in the IO
+
 group.  
 
 
7.3 Results from this clinical trial 
 
Infant orthopedics reduced the alveolar cleft width prior to lipsurgery, 
however, the reduction was relatively small when compared to the 
reduction induced by lipsurgery (chapter 2). The explained variance of IO 
was also very small (10%). At the same time the thickness of the cleft 
margins also increased significantly more when IO was used. It is 
suggested that the alveolar cleft width reduction in the IO
+
 group could 
also be (partially) due to hypertrophy of the soft tissues at the cleft 
margins as a result of wearing a plate with grinded pathways for the 
segments to grow into. This tissue “excess” may disappear when the plate 
is reduced in the labial part after lipsurgery to allow for molding of the 
maxillary segments by the reconstructed lip. Other dimensional effects 
were that IO also temporarily aligned the larger segment towards the 
virtual correct midline before lip closure, but the difference between 
groups disappeared after lip closure. The largest effect of IO was the 
temporary flattening of the palatal vault. The explained variance of IO 
was up to 49%, the highest of all dimensions. These findings are 
supported by findings of Mishima et al.
4,5,6,7
 Comparing the present 
results with the results reported from the Zürich CLP center
8
 the outcome 
regarding maxillary dimensions seems to be equal until soft palate 
closure, which is at a later age (18 mo) in Zürich. Unfortunately, 
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Gnoinski and coworkers never published any results of an untreated 
control group. 
This study showed no significant differences between groups for the 
occurrence of contact and collapse of the maxillary segments (chapter 3). 
Comparing this outcome with the results of Mazaheri et al,
9
 no contact 
was seen before lip closure in the present study, whereas Mazaheri 
already scored contact in about 40% of the cases as early as at 1 month of 
age. Also the percentage of collapse was relatively higher and sooner in 
his study. These differences might reflect differences between the 
surgical protocols. Statements by Kramer et al.
10
 that infant orthopedics 
restricts growth in the transverse direction and by Opitz and Kratzsch
11
 
that wearing an orthopedic plate after lip surgery actually prevents 
collapse in the anterior region could not be sustained. 
From the findings of this study it can be concluded that IO in UCLP 
patients did not relevantly facilitate approximation between the maxillary 
segments prior to lip surgery nor did it prevent collapse of the alveolar 
segments or reduced the severity of collapse from birth until the age of 
18 months. Results from follow-up studies by Bongaarts et al.
12,13
 at the 
age of 4 and 6 confirm the present findings later in life. No differences 
were found between groups regarding maxillary dimensions, contact or  
collapse of the alveolar segments as well as for the dental occlusion in 
the deciduous dentition, including anterior cross bites. 
 Feeding and nutritional status were evaluated in chapter 4. No 
significant differences were found between groups for these feeding 
variables. Infant orthopedics, cleft width and initial cleft width together 
did not explain any variance (R2 < 4.0%) in feeding. The consequent 
nutritional status was evaluated by means of the adopted weight and 
length recordings from the Dutch consultation centers for children‟s 
health. Evaluation of the nutritional status is in accordance with the 
WHO working group
14
 that recommends the use of anthropometric 
assessments in order to evaluate response to treatment. Also the 
anthropometric indices length-for-age and weight-for-length discriminate 
between different physiological and biological processes and the weight-
for-length ratio is sensitive to small weight changes.
15
 The z-scores were 
calculated using the Netherlands third nation wide survey on growth
16
 as 
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a reference. In the present study weight-for-age, length-for-age and 
weight-for-length did not differ significantly between groups. However 
the mean values for the UCLP trial-infants differed significantly from the 
reference. Not only were the UCLP trial infants significantly lighter and 
smaller than the reference also the mean values for weight-for-length 
were lower after soft palate closure than the reference. However this last 
difference might be due to increased missing values at the end of the 
observation period but could support the findings of Felix-Schollaart et 
al.
17 
that feeding difficulties experienced at a relatively late age (12-18 
mo) influence weight and length. The infants from the study of Felix-
Schollaart et al.
17
 had IO during the first 14 to 16 months and suitability 
of the control data were checked using the same national growth study as 
the present study. 
 This study is not the first to imply that infants with UCLP are 
lighter and smaller. Even though literature is not consistent,
18-21
 the 
significance level and the magnitude of the differences show a relevant 
finding. Haschke and Van 't Hof
22
 reported that the educational level of 
the mother did not influence length or weight significantly and that mid-
parent-height significantly influenced length and weight. The background 
variable mid-parent height could have supported the relevance of the 
findings, but the used questionnaire was developed before this 
background variable was found to be important. Nevertheless before soft 
palate closure, which marks the end of IO, the infants from this trial 
showed normal weight for length ratio, which for the infants in question 
is the most important value of all. The claimed advantage that IO would 
result in more effective feeding, by covering the cleft, could not be 
substantiated. 
Facial appearance (chapter 5) was evaluated using full face and 
cropped photographs. It appeared from this part of the study that 
reference scores were more discriminative than VAS (visual analog 
scale). Also full face photographs were judged more attractive than the 
cropped versions. The results regarding facial appearance, however, did 
not differ between the treatment groups as judged by 46 professionals and 
laymen. Naso-alveolar molding (NAM) as described by Grayson et al.
23
 
Grayson and Cutting
24
 and Grayson and Maull,
25
 which is currently a 
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hype, combines IO with extra-oral taping and traction, the authors claim 
the following benefits from retrospective studies: better nose symmetry, 
cost-effectiveness in terms of secondary surgery and no constriction of 
bifacial growth.
26-28
 However all treatment groups in these studies were 
very small, the selection criteria unclear, the control groups were not 
matched and it remains unclear to what extend IO in combination with 
NAM influences the overall score for facial appearance shortly after 
surgery, but more importantly, at longer term. The cost-effectiveness 
should be re-evaluated prospectively in a RCT using the intention to treat 
principle in order to measure the real contribution of NAM. Also 
recordings of non-participating eligible patients and reasons for non 
participation should be performed and analyzed. 
The last item reported in this thesis was the satisfaction in 
motherhood (chapter 6). Due to the impossibility to measure the 
influence of treatment on quality of life at such young ages, this variable 
was chosen as a substitute. Mothers from both groups appeared to be 
satisfied to the same degree. The mean level of satisfaction was 
positioned between very satisfied and satisfied in both groups. No 
significant difference could be found in the appreciation of motherhood 
between mothers with or without the experience with IO, nor could a 
center effect be demonstrated. Mothers were most satisfied with their 
personal contact with the baby whereas they were less satisfied with time 
for other occupations and more importantly with the experienced support 
by professionals. Comparing the two treatment groups no significant 
differences were found. 
 The only significant longer term effect of IO so far has been the 
difference in costs, early overall quality of speech as well as language 
development.
29-31
 Regarding the overall quality of speech at the age of 
2.5 yr it was concluded that the difference between groups was 
significant but small and that speech in CLP children was still not 
adequate in comparison to children without clefts. Language development 
was significantly better in the IO
+
 group at age of 2,5 and 3 yr, but was 
no longer significant after the age of 6 yr. 
 Regarding negative effects of IO the difference in costs, in terms of 
direct and indirect (medical) costs was the only negative side effect of IO 
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measured. However, the occurrence of dental caries was not looked into 
and this could have been an additional negative side effect. A 
simultaneous study by Bokhout et al.
32
 into the effects of IO on caries, 
made extra recordings of this side effect redundant. 
 In conclusion, IO as used in this trial is costly and only cost-
effective regarding a small (temporary) improvement in speech.  
 
 
7.4 Implications for the use of IO, and implementation of the results 
 into daily practice  
 
7.4.1 Status Quo 
No national or international “evidence based” guidelines for CLP 
treatment have been developed in the past. The reasons for the lack of 
scientific evidence to support guidelines are the problems that limit 
researchers: the multidimensionality of outcome, length of follow-up, 
diversity of management, sample sizes and as amplified by the WHO the 
reproducibility and validity of outcome measures.
33-36
 However cleft 
palate associations like the American Cleft Palate-Craniofacial 
Association (ACPA) have published parameters for evaluations and 
treatment; Research groups like Euro cleft, and the British Clinical 
Standards Advisory Group (CSAG) and the WHO have presented 
recommendations regarding research, structure, organization and 
training/education, as well as recommendations to policymakers, to CLP-
teams and to professionals.
37-40
 From these research groups as well as 
from other evaluation- and comparison studies, important and valuable 
information on different aspects of CLP treatment have been elucidated. 
Examples are the importance of a minimal annual case load per team and 
per professional, the experience of the professionals with CLP, but also 
the relative importance of type and timing of surgical interventions.  
This clinical trial, however, has elucidated comprehensive “evidence 
based” information on the effects of IO. Infant orthopedics is not cost -
effective regarding the claimed advantages studied except for, temporary 
limited improved speech quality. It is our conclusion that IO as indicated 
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and performed in this RCT can be abandoned and that this information 
needs to be disseminated and implemented. 
 
7.4.2 Where are we going from here? 
Research dissemination involving the transfer of new evidence to a target 
audience is an essential first step in getting professionals to incorporate 
new findings into clinical practice. However the receipt of new 
knowledge is by far not sufficient to change clinical practices.
41,42
  
Grimshaw: “Health services research consistently demonstrates a gap 
between research-based best clinical practice and what physicians 
actually do. Traditionally, the profession of medicine has behaved as if 
dissemination of research findings in peer-reviewed journals will 
eliminate this gap, even though physicians typically have less than 1 hour 
per week to read. This problem is complicated by the fact that physicians 
have not been trained generally to appraise published research, which is 
of variable quality in any event. Physicians interested in changing their 
practices also encounter organizational, peer group, and individual 
barriers at the same time as they face information overload and patient 
expectations. In a word, physicians‟ abilities to manage information is 
overwhelmed”.42 An implementation strategy is often required to provide 
professionals with the skills and encouragement needed to alter 
established routines, particularly if new findings conflict with community 
norms, which may have been built up over long periods of time as in the 
case of IO. The term implementation strategy describes interventions that 
aim to translate knowledge into changes in practice. In order to facilitate 
evidence dissemination of “new” treatment, guidelines have to be 
generated from the evidence and implementation strategies have to be 
developed.
43,44
 In some medical fields another RCT is needed and 
conducted in order to investigate the most (cost-)effective way of 
implementation for the professional and the patient. According to 
Grimshaw, however, further research is also needed in this field and 
decision makers need to use considerable judgment about how to best use 
the limited resources they have for clinical governance and related 
activities to maximize population‟s benefits. They also need to consider 
the potential clinical areas for clinical effectiveness activities, the likely 
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benefits and costs required to introduce guidelines and the likely benefits 
and costs as a result of any changes in provider behavior. 
A suggestion for further implementation of the present evidence in the 
Netherlands would be to install a (national) CFA advisory group to set up 
guidelines in general but for this moment for the use of IO in UCLP 
treatment. Keeping in mind that guidelines become outdated and should 
be reassessed for validity every 3 years.
45
 Since the most cost-effective 
alternative from this study is „no treatment‟ the guideline, for the coming 
3 years, should suggest not to use IO of this type in UCLP. Suggestions 
for the implementation strategies could entail: a special conference and 
administration of the guideline held by the national advisory group and 
the national CLP Association (NVSCA), and /or an administration of the 
guideline(s) send to the CLP teams in The Netherlands. Assessment of 
the effectiveness of the new guideline could also be part of the quality 
management of the (national) CFA advisory group. 
In the participating CLP centers implementation of the results was 
performed immediately after the end of the intake period. It was one of 
the aims of the preliminary evaluation to use the available information at 
that time in order to develop a temporary treatment guideline for the 
participating centers after the intake period had ended. Infant orthopedics 
was abandoned and is currently only performed in BCLP and in rare 
extreme cases of CLP or CP.  
 
  
7.5 Directions for future research 
 
From the present study and the studied literature it was concluded that 
directions for future research concern the use of reproducible and valid 
outcome measures on the aspects: support, care and given information to 
the parents, psychological condition of the parents especially regarding 
parental stress, resilience of the patient and possible presence of 
unrealistic expectations regarding treatment outcome. It is also noticed 
that research into the effects of treatment often fails to address questions 
that matter to the patients and to the professionals to whom they turn for 
help. The James Lind Alliance tries to bring patients and clinicians 
General discussion  
 133 
together in „Working Partnerships‟ to identify and prioritize the 
unanswered questions that they agree are most important 
(www.lindalliance.org).
46
  
It was the aim of this study to close all the gaps in knowledge regarding 
the effects of IO by trying to include all relevant aspects and subsequent 
variables. But it remains unknown if this study also has addressed the 
questions parents or patients may have (had)  regarding the use of IO. We 
are still in great need for more scientific evidence regarding our 
performances and care, the QoL of our patients as well as the interaction 
of QoL with treatment
47 
and as stated by the James-Lind-Alliance we 
have to make an inventory of, and evaluate what, our patients and their 
parents want to know!  
The mission for the future will be the implementation of the evidence 
found in this study and to urge cleft palate teams to (re)evaluate their 
treatment protocols and to collaborate in randomized clinical trials. 
Remembering that evidence based medicine does not provide absolute 
answers it simply helps professionals to make decisions. 
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Summary 
 
Unilateral cleft lip and palate (UCLP) is a complex congenital anomaly. 
The anomaly is associated with numerous problems and consequent 
treatments to solve them but often with remaining handicaps to live with. 
Through time researchers have elucidated many aspects of these 
associated problems and their optimal treatment, of the psycho-social 
wellbeing of the affected individuals and recently also some aspects of 
their quality of life. Research into the effectiveness of treatment in CLP 
is however limited by amongst others the low prevalence and the long 
follow up period. Current research is focused to enhance knowledge 
regarding the etiology of CLP, prevention of CLP, the effectiveness of 
CLP treatment and the quality of life. One of the treatment modalities 
that is performed during infancy is infant orthopedics (IO), a treatment 
performed with a passive acrylic plate during early infancy in order to 
narrow the cleft. This controversial treatment modality however appeared 
to be insufficiently evidence based which was one of the objectives to 
initiate this study. It was the aim of this clinical trial to evaluate the 
effectiveness of IO. Because of the low prevalence the cleft palate centers 
of Amsterdam, Nijmegen and Rotterdam participated. At the onset of this 
clinical trial IO was part of UCLP treatment protocol in all 3 centers. In 
this clinical trial 2 computer randomized treatment groups were evaluated 
comprehensively, one group was treated with IO during the first year of 
life the second group was not. In order to accomplish this, relevant 
domains were identified and included and relevant and representative 
variables were measured. Four domains were identified and evaluated 
i.e.: general aspects, surgical and orthodontic aspects, speech/language 
development and costs of treatment. The latter in order to perform a cost 
effectiveness analysis. This thesis presents the results of the first two 
domains. General aspects of IO included feeding, nutritional status, and a 
substitute for the patients quality of life, satisfaction in motherhood. The 
surgical and orthodontic aspects included maxillary morphology, growth 
and development, and facial appearance. Results from these parts of the 
study are presented and discussed in chapter 2 to 7. It was concluded 
from these chapters that IO had a small temporary effect on some of the 
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maxillary dimensions. However no differences were found for the 
different feeding variables and the consequent nutritional status although 
the infants appeared to be shorter and lighter then their normal peers. The 
facial appearance did not differ between treated and non treated infants 
nor did the satisfaction in motherhood. All in all it could be concluded 
from this thesis that IO can be discarded from the UCLP treatment 
protocol. This conclusion was supported by the results from the other two 
domains and by recent follow-up studies. Regarding the implementation 
of the temporary guidelines, resulted from the findings of the present 
study, it should be mentioned that IO is no longer part of the normal 
treatment protocol in UCLP in the participating cleft palate centers of 
Amsterdam, Nijmegen and Rotterdam. 
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Samenvatting 
 
Enkelzijdige lip-, kaak-, en gehemeltespleten (UCLP) zijn complexe 
aangeboren afwijkingen. Deze afwijkingen vragen een uitgebreide 
behandeling en uiteindelijk is er sprake van lichte overblijvende 
handicaps, waar de patiënt verder mee door het leven moet. Vele aspecten 
van de geassocieerde problemen, de optimale behandeling ervan en de 
bijbehorende psychosociale problemen werden al door onderzoek 
opgehelderd, en er is een begin gemaakt met onderzoek naar de kwaliteit 
van leven bij UCLP. Beperkingen in het onderzoek naar UCLP zijn 
vooral de lage prevalentie en de lange follow-up periode. Thans is 
onderzoek vooral gefocust op de etiologie van schisis, de preventie ervan, 
de effectiviteit van behandelingen en op de kwaliteit van leven.  
Een van de onderdelen in het behandelprotocol bij UCLP is de 
behandeling met het zogenaamde gehemelteplaatje of ‘infant orthopedics’ 
(IO) in het Engels, een behandeling die gedurende het eerste levensjaar 
wordt uitgevoerd met behulp van een plaatje van acryl in de bovenkaak 
teneinde de spleet in de bovenkaak te versmallen. Deze controversiële 
behandeling bleek onvoldoende “evidence based” (bewezen) wat mede de 
aanleiding vormde voor dit onderzoek.  
Het doel van deze clinical trial was de effectiviteit van infant 
orthopedics (IO) te onderzoeken, waarbij gezien de lage prevalentie drie 
schisiscentra werden betrokken te weten Nijmegen, Amsterdam en 
Rotterdam. Infant orthopedics was een behandeling die tot dan toe 
onderdeel vormde van behandelprotocol van UCLP in deze centra. Er 
werd zoveel mogelijk naar gestreefd de effectiviteit alles omvattend te 
onderzoeken. Om dit doel te bereiken werden kinderen met UCLP naar 2 
behandelgroepen gerandomiseerd. In de eerste groep werd een plaatje 
gebruikt gedurende het eerste levensjaar, in de tweede groep werd dit 
achterwege gelaten. Alle relevante domeinen werden geïdentificeerd en 
alle relevante en representatieve variabelen gemeten. Er werd 
onderscheid gemaakt tussen 4 domeinen te weten; algemene aspecten; 
orthodontische en chirurgische aspecten; spraak/taal ontwikkeling; en de 
kosten van de behandeling. Dit laatste teneinde een 
kosteneffectiviteitanalyse uit te kunnen voeren. In dit proefschrift werden 
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de resultaten weergegeven van de eerste 2 domeinen. Het domein 
algemene aspecten van IO omvat de voeding en de bijbehorende 
algemene groei en ontwikkeling, evenals een benadering van de kwaliteit 
van leven te weten, tevredenheid in het moederschap. De orthodontische 
en chirurgische aspecten omvatten de morfologie van de bovenkaak, de 
groei en ontwikkeling van de bovenkaak en de esthetiek van het gezicht. 
De resultaten van deze onderdelen van de clinical trial werden 
weergegeven en bediscussieerd in de hoofdstukken 2 tot en met 7.  
In het kort kan worden geconcludeerd dat IO een klein doch tijdelijk 
effect heeft op enkele dimensies in de bovenkaak. Er werden geen 
verschillen gevonden voor de variabele voeding noch voor de algemene 
groei en ontwikkeling. Kinderen in beide onderzoeksgroepen bleken 
echter kleiner en lichter dan de normale populatie. De esthetiek van het 
gezicht was niet significant verschillend tussen beide onderzoeksgroepen 
noch was dit het geval voor de tevredenheid in het moederschap.  
Alles in overweging nemende kan uit dit proefschrift worden 
geconcludeerd dat IO uit het behandelprotocol voor UCLP kan worden 
verwijderd. Deze conclusie werd ook gesteund door de resultaten van de 
laatste 2 domeinen evenals door de recent gepubliceerde follow-up 
studies. De implementatie van  de voorlopige richtlijnen geformuleerd 
naar aanleiding van de onderzoeksgegevens heeft tot gevolg gehad dat IO 
geen onderdeel meer is van het standaard behandelprotocol bij kinderen 
geboren met een UCLP in de participerende schisiscentra Nijmegen, 
Amsterdam en Rotterdam. 
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